From 22a1ee9821ade888f880a4ccc5ef5171fab0901a Mon Sep 17 00:00:00 2001 From: Kamran Date: Tue, 10 Dec 2024 21:26:29 +0600 Subject: [PATCH] ent written questions collection --- .obsidian/workspace.json | 22 +-- journals/2024_12_10.md | 5 + .../.recycle/pages_Furunculosis.md | 46 ++--- logseq/.recycle/pages_Nasal Allergy.md | 72 ++++++++ .../Nose/2024-12-10T11_32_27.392Z.Desktop.md | 10 + .../2024-12-10T11_32_27.393Z.Desktop.md | 18 ++ pages/Absolute Bone Conduction Test.md | 3 + pages/Achalasia Cardia.md | 87 ++++----- pages/Acute Epiglottitis.md | 95 +++++----- pages/Acute Laryngitis.md | 75 ++++++++ pages/Acute Mastoiditis.md | 103 ++++++----- pages/Acute Maxillary Sinusitis.md | 95 +++++----- pages/Acute Retropharyngeal Abscess.md | 117 ++++++------ pages/Acute Suppurative Otitis Media.md | 108 ++++++----- pages/Acute Tonsilitis.md | 174 +++++++++--------- pages/Adenoidectomy.md | 6 +- pages/Allergic Rhinitis.md | 100 +++++----- pages/Anterior Nasal Packing.md | 6 + ...antral Chronic Suppurative Otitis Media.md | 102 +++++----- pages/Antral Washout.md | 7 +- pages/Apyrexial Laryngeal Stridor.md | 6 + pages/Atrophic Rhinitis.md | 102 +++++----- pages/Branchial Cyst.md | 77 ++++++++ pages/Carcinoma Larynx.md | 103 ++++++----- pages/Cholesteatoma.md | 110 +++++------ pages/Chronic Maxillary Sinusitis.md | 98 +++++----- pages/Chronic Retropharyngeal Abscess.md | 97 +++++----- pages/Chronic Suppurative Otitis Media.md | 127 +++++++------ pages/Cochlear Implant.md | 3 + pages/Conductive Type of Hearing Loss.md | 13 +- pages/Congenital Neck Swelling.md | 9 + pages/Cornea.md | 2 + pages/Corrosive Burn of Esophagus.md | 3 + pages/Deviated Nasal Septum.md | 91 ++++----- pages/Diptheria.md | 11 +- pages/Discharging Ear.md | 5 + pages/Dysphagia.md | 11 +- pages/ENT Question Summary.md | 6 + pages/Enlarged Adenoid.md | 89 ++++++++- pages/Epistaxis.md | 162 ++++++++-------- pages/Esophageal Perforation.md | 94 +++++----- pages/Esophagoscopy.md | 17 +- pages/Esophagus.md | 1 + pages/Ethmoidal Polyp.md | 106 ++++++----- pages/Eustachian Tube.md | 8 +- pages/Foreign Body in Ear.md | 9 +- pages/Foreign Body in Esophagus.md | 103 ++++++----- pages/Foreign Body in Larynx.md | 94 +++++----- pages/Foreign Body in Nose.md | 93 +++++----- pages/Functional Endoscopic Sinus Surgery.md | 10 +- pages/Furunculosis.md | 46 +++-- pages/Impedance Audiogram.md | 3 + pages/Lateral Neck Swelling.md | 9 + pages/Littles Area.md | 11 +- pages/Ludwig's Angina.md | 87 ++++----- pages/Mastoid Abscess.md | 76 ++++++++ pages/Mastoidectomy.md | 26 ++- pages/Mastoiditis.md | 72 ++++++++ pages/Mechanism of Swallowing.md | 3 + pages/Meniere's Disease.md | 95 +++++----- pages/Middle Ear.md | 9 +- pages/Midline Neck Swelling.md | 4 +- pages/Multiple Papilloma of Larynx.md | 95 +++++----- pages/Myringoplasty.md | 3 + pages/Myringotomy.md | 3 + pages/Nasal Discharge.md | 7 + pages/Nasal Obstruction.md | 13 +- pages/Nasal Polyp.md | 124 +++++++------ pages/Nasal Septum.md | 8 +- pages/Neck Swelling.md | 6 - pages/Nose.md | 10 +- pages/Ocular Chemical Injury.md | 4 +- pages/Ostosclerosis.md | 95 +++++----- pages/Otitis Externa.md | 32 +++- pages/Otitis Media with Effusion.md | 111 ++++++----- pages/Otitis Media.md | 74 ++++++++ pages/Otomycosis.md | 33 ++-- pages/Pain and Tenderness in Ear.md | 3 + pages/Parotid Gland Enlargement.md | 3 + pages/Plummer Vinson Syndrome.md | 3 + pages/Pre-auricular Sinus.md | 72 ++++++++ pages/Pure Tone Audiometry.md | 5 + pages/Ranula.md | 3 + pages/Recurrent Miscarriage.md | 3 +- pages/Reddish Mass of Nose.md | 3 + pages/Referred Otalgia.md | 7 +- pages/Retropharyngeal abscess.md | 96 +++++----- pages/Rhinnes Test.md | 6 + pages/Rhinoplasty.md | 3 + pages/Rhinosporidiosis.md | 98 +++++----- pages/Rinne's Test.md | 9 + pages/Rough Query.md | 3 + pages/Sensorineural Deafness.md | 76 +------- pages/Septal Abscess.md | 97 +++++----- pages/Septal Hematoma.md | 95 +++++----- pages/Septoplasty.md | 19 +- pages/Stridor.md | 18 +- pages/Submandibular Gland Surgery.md | 6 + pages/Submucosal Resection.md | 4 + pages/Syringing the Ear.md | 7 +- pages/Tests of Ear.md | 9 + pages/Thryroglossal Duct.md | 72 ++++++++ pages/Thyroid Swelling.md | 3 + pages/Tongue Ulcer.md | 3 + pages/Tonsillectomy.md | 67 ++++--- pages/Tracheostomy.md | 19 +- ...mpanic Chronic Suppurative Otitis Media.md | 90 ++++----- pages/Tympanic Membrane.md | 20 +- pages/Tympanoplasty.md | 3 + pages/Vertigo.md | 94 +++++----- pages/Waldeyer's Ring.md | 20 +- pages/Wax.md | 21 ++- pages/Weber Test.md | 6 + pages/White Patches on the tonsil.md | 3 + pages/contents.md | 4 +- pages/ent-prof-written.md | 1 + pages/juvenile nasopharyngeal angiofibroma.md | 5 +- pages/larynx.md | 9 + 118 files changed, 3073 insertions(+), 1985 deletions(-) rename pages/Furuncle.md => logseq/.recycle/pages_Furunculosis.md (52%) create mode 100644 logseq/.recycle/pages_Nasal Allergy.md create mode 100644 logseq/bak/pages/Nose/2024-12-10T11_32_27.392Z.Desktop.md create mode 100644 logseq/bak/pages/Tympanic Membrane/2024-12-10T11_32_27.393Z.Desktop.md create mode 100644 pages/Absolute Bone Conduction Test.md create mode 100644 pages/Acute Laryngitis.md create mode 100644 pages/Anterior Nasal Packing.md create mode 100644 pages/Apyrexial Laryngeal Stridor.md create mode 100644 pages/Branchial Cyst.md create mode 100644 pages/Cochlear Implant.md create mode 100644 pages/Congenital Neck Swelling.md create mode 100644 pages/Corrosive Burn of Esophagus.md create mode 100644 pages/Discharging Ear.md create mode 100644 pages/ENT Question Summary.md create mode 100644 pages/Esophagus.md create mode 100644 pages/Impedance Audiogram.md create mode 100644 pages/Lateral Neck Swelling.md create mode 100644 pages/Mastoid Abscess.md create mode 100644 pages/Mastoiditis.md create mode 100644 pages/Mechanism of Swallowing.md create mode 100644 pages/Myringoplasty.md create mode 100644 pages/Myringotomy.md create mode 100644 pages/Nasal Discharge.md delete mode 100644 pages/Neck Swelling.md create mode 100644 pages/Otitis Media.md create mode 100644 pages/Pain and Tenderness in Ear.md create mode 100644 pages/Parotid Gland Enlargement.md create mode 100644 pages/Plummer Vinson Syndrome.md create mode 100644 pages/Pre-auricular Sinus.md create mode 100644 pages/Pure Tone Audiometry.md create mode 100644 pages/Ranula.md create mode 100644 pages/Reddish Mass of Nose.md create mode 100644 pages/Rhinnes Test.md create mode 100644 pages/Rhinoplasty.md create mode 100644 pages/Rinne's Test.md create mode 100644 pages/Rough Query.md create mode 100644 pages/Submandibular Gland Surgery.md create mode 100644 pages/Tests of Ear.md create mode 100644 pages/Thryroglossal Duct.md create mode 100644 pages/Thyroid Swelling.md create mode 100644 pages/Tongue Ulcer.md create mode 100644 pages/Tympanoplasty.md create mode 100644 pages/Weber Test.md create mode 100644 pages/ent-prof-written.md create mode 100644 pages/larynx.md diff --git a/.obsidian/workspace.json b/.obsidian/workspace.json index ec794fb..63c3cc1 100644 --- a/.obsidian/workspace.json +++ b/.obsidian/workspace.json @@ -4,21 +4,17 @@ "type": "split", "children": [ { - "id": "ba8490928400e18d", + "id": "2bdea1e21f1dbc3d", "type": "tabs", "children": [ { - "id": "682b879877ec909c", + "id": "977b375358a91d37", "type": "leaf", "state": { - "type": "markdown", - "state": { - "file": "logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-09T11_06_23.310Z.Desktop.md", - "mode": "source", - "source": false - }, + "type": "empty", + "state": {}, "icon": "lucide-file", - "title": "2024-12-09T11_06_23.310Z.Desktop" + "title": "New tab" } } ] @@ -52,7 +48,7 @@ "state": { "type": "search", "state": { - "query": "tag:#ent-prof-card", + "query": "tag:#ent-prof-card tag:#card", "matchingCase": false, "explainSearch": true, "collapseAll": false, @@ -163,8 +159,12 @@ "command-palette:Open command palette": false } }, - "active": "e9eec337ac40e078", + "active": "977b375358a91d37", "lastOpenFiles": [ + "logseq/bak/pages/Thyroidectomy/2024-12-09T11_06_23.322Z.Desktop.md", + "logseq/bak/pages/Hoarseness of Voice/2024-12-09T11_06_23.321Z.Desktop.md", + "logseq/bak/pages/Brachial Cyst/2024-12-09T11_06_23.303Z.Desktop.md", + "logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-09T11_06_23.310Z.Desktop.md", "pages/Syringing the Ear.md", "pages/Wax.md", "journals/2024_12_09.md", diff --git a/journals/2024_12_10.md b/journals/2024_12_10.md index e69de29..2e1262c 100644 --- a/journals/2024_12_10.md +++ b/journals/2024_12_10.md @@ -0,0 +1,5 @@ +- Gyne - abortion +- obs - normal labor +- pedi - 5 cards +- eye - 10 cards +- ent - 70 cards \ No newline at end of file diff --git a/pages/Furuncle.md b/logseq/.recycle/pages_Furunculosis.md similarity index 52% rename from pages/Furuncle.md rename to logseq/.recycle/pages_Furunculosis.md index 677a0fa..3d21524 100644 --- a/pages/Furuncle.md +++ b/logseq/.recycle/pages_Furunculosis.md @@ -1,16 +1,13 @@ -alias:: Localized Acute Otitis Externa -ICD-11_Code:: -tags:: #Disease - -- #definition {{c1 A furuncle is a staphylococcal infection of the hair follicle}} #ent-prof-card #card #[[External Ear]] +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 Recurrent or multiple [[Furuncle]]s is called Furunculosis }} #ent-prof-card #unanswered #card + id:: 6756a8ab-4837-43bd-8f2a-5e5a48df80fa deck:: #ENT - id:: 67579687-462c-4d72-a007-b7aabc820878 - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-card #card #[[External Ear]] - deck:: #ENT - id:: c3ed9276-100a-4ae9-8b22-5374b5db6310 - - [[Staphylococcus aureus]] + id:: 6756cf33-62f1-4697-b808-6abef9e42e55 + - ### Causative Agents - ### Risk Factors - ## Epidemiology background-color:: blue @@ -18,16 +15,16 @@ tags:: #Disease - ### Prevalence - ### Demographics - ### Geographic Distribution -- ## Pathophysiology #ent-prof-card #card #[[External Ear]] +- ## Pathophysiology #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT - id:: bcf7efa7-463f-4fe6-af30-cee75433b2ed + id:: f0515a7d-e1eb-4340-981b-5b843b5bb246 - ### Mechanism of Disease - - infection of the hair follicles of external ear by [[Staphylococcus aureus]] - ### Affected Systems/Organs - - only the cartilagenous part comprises the hair follicles, hence Furuncle is confined to cartilagenous part of external ear -- ## Clinical Features +- ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue + deck:: #ENT + id:: e445fb66-0f09-4bbf-a956-f1602db091af - ### Signs and Symptoms - #### Symptoms - #### Signs @@ -42,24 +39,13 @@ tags:: #Disease - ### Imaging Studies - ### Differential Diagnosis - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #card #[[External Ear]] +- ## Management and Treatment background-color:: blue - deck:: #ENT - id:: 3af07f85-c7db-408f-a49b-e78a42fe5ebd + id:: 0103a3c3-347d-4f75-8dfc-57f0e330cc30 - ### Medical Treatment - - Systemic Antibiotics - - Analgesics - - Local Heat - - Ear pack of 10% ichthammol glycerine provides splintage and reduces pain - - Hygroscopic action of glycerine reduces oedema - - ichammol is mildly antiseptic - ### Surgical Options - if abscess formed - - incision and drainage of abscess - - If recurrent [[Furunculosis]] - - Exclude diabetes - - Attention paid to the patient's nasal vestibules which may harbour staphylococci and the infection transferred by patient's fingers - - Staphylococcal infections of the skin as a possible source should also be excluded and suitably treated + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - ### Expected Course diff --git a/logseq/.recycle/pages_Nasal Allergy.md b/logseq/.recycle/pages_Nasal Allergy.md new file mode 100644 index 0000000..b400c9f --- /dev/null +++ b/logseq/.recycle/pages_Nasal Allergy.md @@ -0,0 +1,72 @@ +alias:: [[Allergic Rhinitis]] +ICD-11_Code:: +tags:: #Disease + +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue \ No newline at end of file diff --git a/logseq/bak/pages/Nose/2024-12-10T11_32_27.392Z.Desktop.md b/logseq/bak/pages/Nose/2024-12-10T11_32_27.392Z.Desktop.md new file mode 100644 index 0000000..9ec555f --- /dev/null +++ b/logseq/bak/pages/Nose/2024-12-10T11_32_27.392Z.Desktop.md @@ -0,0 +1,10 @@ +# Function #ent-prof-card #unanswered #card + +id:: 6756bce7-9deb-455d-a154-f47b658dd652 +- ## deck:: #ENT +- # Protective Functions of Nose #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675806a3-1ca4-4f91-aeaf-3c6df7891042 +- # Autonomic Nerve Supply of Nose and [[Paranasal Sinuses]] #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675806ba-ab33-4b4a-9aeb-4ea731da131c \ No newline at end of file diff --git a/logseq/bak/pages/Tympanic Membrane/2024-12-10T11_32_27.393Z.Desktop.md b/logseq/bak/pages/Tympanic Membrane/2024-12-10T11_32_27.393Z.Desktop.md new file mode 100644 index 0000000..e8c81f9 --- /dev/null +++ b/logseq/bak/pages/Tympanic Membrane/2024-12-10T11_32_27.393Z.Desktop.md @@ -0,0 +1,18 @@ +alias:: Ear Drum + +- # Parts #ent-prof-card #unanswered #card + + id:: 6756ce4d-a0eb-49b6-8900-ca2958757ab5 +- ## deck:: #ENT +- # Drawing and Labelling #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f920-b409-4035-ac18-08fa605588ba +- # Drawing and Labelling Tympanic Membrane showing **Central Perforation** #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f968-6d4f-4dee-9395-19ab2dc66e85 +- #Drawing and Labelling Tympanic Membrane showing Marginal Perforation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f984-43fa-49e8-b8ef-42052d8276cf +- # 5 causes of traumatic Injury to the Tympanic Memrbane #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f9c7-f5b3-46d3-af0b-ee3f47381dda \ No newline at end of file diff --git a/pages/Absolute Bone Conduction Test.md b/pages/Absolute Bone Conduction Test.md new file mode 100644 index 0000000..9410028 --- /dev/null +++ b/pages/Absolute Bone Conduction Test.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758027c-89e4-4a7e-845d-641b9d65bb18 \ No newline at end of file diff --git a/pages/Achalasia Cardia.md b/pages/Achalasia Cardia.md index 61008e7..6aa03fd 100644 --- a/pages/Achalasia Cardia.md +++ b/pages/Achalasia Cardia.md @@ -5,71 +5,74 @@ background-color:: blue deck:: #ENT id:: 36de9f45-68c5-4331-8e37-c3daf391bb23 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 52c64503-bf27-4d6a-8474-e752eb17a295 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 2d2ff087-298c-43ec-a324-fce7ddfa9dfa - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675813a2-a798-47ba-bba1-392a69a7cf38 \ No newline at end of file diff --git a/pages/Acute Epiglottitis.md b/pages/Acute Epiglottitis.md index 5576655..4bff9a1 100644 --- a/pages/Acute Epiglottitis.md +++ b/pages/Acute Epiglottitis.md @@ -5,75 +5,78 @@ background-color:: blue deck:: #ENT id:: 679efe77-ff1d-4c8d-888c-abb551b9ada2 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 594754be-5664-46ab-8213-ccbed28261b5 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Acute Laryngotracheobronchitis]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b395-74e9-4b44-83bd-651dc5aeded1 - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Acute Laryngotracheobronchitis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b395-74e9-4b44-83bd-651dc5aeded1 + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 4ef3c41d-da98-42b2-ae51-71ddb4f116d4 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580fed-6ad9-45f9-9c83-6b554715552c \ No newline at end of file diff --git a/pages/Acute Laryngitis.md b/pages/Acute Laryngitis.md new file mode 100644 index 0000000..fdf6c0c --- /dev/null +++ b/pages/Acute Laryngitis.md @@ -0,0 +1,75 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 9c1b0671-985d-41cb-ab1a-7d403b931838 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 5bad003f-1989-4a3b-9331-d92c22d0995e + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 88d388de-0c35-4441-9068-dfb8f5b28f50 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue \ No newline at end of file diff --git a/pages/Acute Mastoiditis.md b/pages/Acute Mastoiditis.md index 63c313d..586adc9 100644 --- a/pages/Acute Mastoiditis.md +++ b/pages/Acute Mastoiditis.md @@ -3,71 +3,78 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: ccd50f0e-f676-42f1-b879-d7518c4828c3 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Furunculosis]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756bf74-1837-4386-b65d-01fd1761851d - - ### Confirmation of Diagnosis -- ## Management and Treatment + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bf74-1837-4386-b65d-01fd1761851d + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + id:: e90e31bf-d0f0-4ba7-ba3a-9c39398d3eb5 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ffdb-17b0-4334-81bf-65dedfdc9354 \ No newline at end of file diff --git a/pages/Acute Maxillary Sinusitis.md b/pages/Acute Maxillary Sinusitis.md index de550f8..77607b7 100644 --- a/pages/Acute Maxillary Sinusitis.md +++ b/pages/Acute Maxillary Sinusitis.md @@ -5,73 +5,76 @@ background-color:: blue deck:: #ENT id:: 3fae41d5-d42b-4c21-9e86-58cedddcc339 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 00ed145a-4123-46b2-8747-008133352fc0 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: e0e6c817-331f-4915-8c21-e69e459165b0 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580b82-e50f-4cde-a16e-f7d4b1436be9 \ No newline at end of file diff --git a/pages/Acute Retropharyngeal Abscess.md b/pages/Acute Retropharyngeal Abscess.md index f2c91ce..92f05f5 100644 --- a/pages/Acute Retropharyngeal Abscess.md +++ b/pages/Acute Retropharyngeal Abscess.md @@ -1,80 +1,91 @@ - alias:: ICD-11_Code:: tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675810f9-674c-4fbc-b426-cfaf80f94596 - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents #ent-prof-written #unanswered #card + deck:: #ENT + id:: 25b9a42f-a66c-4373-9430-b840179b9c7e + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 27392bbe-50d1-4650-837d-dccf4f455d4f - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b61f-4520-49bf-a222-e8244026dcf1 - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Chronic Retropharyngeal Abscess]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ae63-85c1-4975-92c6-81bccebb2bfb - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b61f-4520-49bf-a222-e8244026dcf1 + - ### Typical Radiological Features #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581125-937a-4643-916e-2a9d4f1d223a + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Chronic Retropharyngeal Abscess]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ae63-85c1-4975-92c6-81bccebb2bfb + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 32ecf5df-62d9-4669-bf18-94d0b5189c9d - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758116b-0463-45d8-b849-9d0a266d1fe1 \ No newline at end of file diff --git a/pages/Acute Suppurative Otitis Media.md b/pages/Acute Suppurative Otitis Media.md index 9b21b43..3cb9aba 100644 --- a/pages/Acute Suppurative Otitis Media.md +++ b/pages/Acute Suppurative Otitis Media.md @@ -6,77 +6,83 @@ tags:: #Disease background-color:: blue deck:: #ENT id:: 6756cf32-3a7b-41ed-8fea-a0f681ae9e7d - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 782d278c-2df9-4263-8e34-97ecc224a950 - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - # Why Quite Frequent in Infants and Children #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fa48-ff98-449d-a3ed-3ba27e8a7f71 + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: a75925d6-4e7c-4bb5-b330-4c6e4c33c818 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: b1c1548a-73e5-4d11-9249-1f0f1b2b101e - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ### Treatment In Post Perforative Stage #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757faf1-6140-42af-a322-da47ed1398b6 - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: 06d1b4e7-12da-40c3-9f32-d0f47a801483 - - ##### Sequel #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756cf32-6112-4fa1-81f0-3f85ea01f0ab - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Complications #ent-prof-card #unanswered #card + deck:: #ENT + id:: 06d1b4e7-12da-40c3-9f32-d0f47a801483 + - ##### Sequel #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf32-6112-4fa1-81f0-3f85ea01f0ab + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Acute Tonsilitis.md b/pages/Acute Tonsilitis.md index 581001c..98b20e4 100644 --- a/pages/Acute Tonsilitis.md +++ b/pages/Acute Tonsilitis.md @@ -3,117 +3,117 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### 3 important causes of unilateral tonsillar enlargement #ent-prof-written #card - deck:: #ENT - id:: 6756d082-fbe1-4362-8a50-35ce92742f7a - - ### Risk Factors + - ### Causative Agents + - ### 3 important causes of unilateral tonsillar enlargement #ent-prof-written #card + deck:: #ENT + id:: 6756d082-fbe1-4362-8a50-35ce92742f7a + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 6733ccec-0fd5-4d94-a031-50fd073d4404 - - ### Signs and Symptoms - - #### Symptoms - - Severe sore throat - logseq.order-list-type:: number - - Dysphagia - logseq.order-list-type:: number - - Fever - logseq.order-list-type:: number - - Odynophagia - logseq.order-list-type:: number - - Unable to open mouth - logseq.order-list-type:: number - - Change of voice - logseq.order-list-type:: number - - Earache (referred pain or the result of acute otitis media as a complication) - logseq.order-list-type:: number - - #### Signs - - Temperature high (102ºF to 104ºF) - logseq.order-list-type:: number - - Tonsil - swollen, oedematous, congested, pus over the tonsil - logseq.order-list-type:: number - - Jugulo digastric lymph node - enlarged and tender - logseq.order-list-type:: number - - Surrounding soft tissue (pillar, soft palate, uvula) - congested - logseq.order-list-type:: number - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - Severe sore throat + logseq.order-list-type:: number + - Dysphagia + logseq.order-list-type:: number + - Fever + logseq.order-list-type:: number + - Odynophagia + logseq.order-list-type:: number + - Unable to open mouth + logseq.order-list-type:: number + - Change of voice + logseq.order-list-type:: number + - Earache (referred pain or the result of acute otitis media as a complication) + logseq.order-list-type:: number + - #### Signs + - Temperature high (102ºF to 104ºF) + logseq.order-list-type:: number + - Tonsil - swollen, oedematous, congested, pus over the tonsil + logseq.order-list-type:: number + - Jugulo digastric lymph node - enlarged and tender + logseq.order-list-type:: number + - Surrounding soft tissue (pillar, soft palate, uvula) - congested + logseq.order-list-type:: number + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - ### Investigations - - CBC: Neutrophilic leukocytosis - - Throat swab for culture and sensitivity - - ### Imaging Studies - - ### Differential Diagnosis #ent-prof-written #card - deck:: #ENT - id:: 6756d014-278c-406e-a192-6887a71c7666 - - ### Differential Diagnosis + - ### Clinical Diagnosis + - ### Investigations + - CBC: Neutrophilic leukocytosis + - Throat swab for culture and sensitivity + - ### Imaging Studies + - ### Differential Diagnosis #ent-prof-written #card + deck:: #ENT + id:: 6756d014-278c-406e-a192-6887a71c7666 + - ### Differential Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #ent-prof-written #card background-color:: blue deck:: #ENT id:: 6733ccec-59ce-49d1-91d1-710b3d517df6 - - ### Medical Treatment - - Broad spectrum antibiotics: [[Cefixime]] 200 mg / [[Cefuroxime]] 200 mg [[TDS]] - - Analgesics: [[Aspirin]], [[Paracetamol]] - - Antipyratics - - Nutrition maintain - liquid and soft solid food should be given - - Avoid cold - - Gurgling - - Bed rest - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations + - ### Medical Treatment + - Broad spectrum antibiotics: [[Cefixime]] 200 mg / [[Cefuroxime]] 200 mg [[TDS]] + - Analgesics: [[Aspirin]], [[Paracetamol]] + - Antipyratics + - Nutrition maintain - liquid and soft solid food should be given + - Avoid cold + - Gurgling + - Bed rest + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Complications background-color:: blue - - ### Possible Complications #ent-prof-written #card - deck:: #ENT - id:: 6733ccec-a955-46e4-8e41-16435a23d761 - - #### Local - - [[Chronic Tonsilitits]] - - [[Peritonsillar abscess]] - - [[Retropharyngeal abscess]] - - [[Airway obstruction]] - - #### General - - [[Septicemia]] - - [[Rheumatic Fever]] - - [[AGN]] - - ### Long-term Effects + - ### Possible Complications #ent-prof-written #card + deck:: #ENT + id:: 6733ccec-a955-46e4-8e41-16435a23d761 + - #### Local + - [[Chronic Tonsilitits]] + - [[Peritonsillar abscess]] + - [[Retropharyngeal abscess]] + - [[Airway obstruction]] + - #### General + - [[Septicemia]] + - [[Rheumatic Fever]] + - [[AGN]] + - ### Long-term Effects - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Adenoidectomy.md b/pages/Adenoidectomy.md index 271f2e4..61c679c 100644 --- a/pages/Adenoidectomy.md +++ b/pages/Adenoidectomy.md @@ -2,7 +2,7 @@ deck:: #ENT id:: 6756b20d-4737-4be6-a805-51d67da83b14 - -- # Postoperative Complications #ent-prof-card #unanswered #card - deck:: #ENT +- # Postoperative Complications of Adenoidectomy #ent-prof-card #unanswered #card id:: 6756b219-4c90-4cd6-9ad0-94a78e34ae37 + deck:: #ENT +- SN: Important complications of adenoid operation \ No newline at end of file diff --git a/pages/Allergic Rhinitis.md b/pages/Allergic Rhinitis.md index 28dea37..896076a 100644 --- a/pages/Allergic Rhinitis.md +++ b/pages/Allergic Rhinitis.md @@ -1,73 +1,79 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease +alias:: Nasal Allergy +ICD-11_Code:: +tags:: #Disease + - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: b1a89f71-c40c-4f6d-b9b5-94bd9c0b80de - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 72e3ee78-26ee-49d6-ab82-23fbaefdcc05 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7d0d3a9a-d02d-4cf1-bd50-c786494f96a6 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ab5-3112-4ea5-a899-574a3677ebe8 \ No newline at end of file diff --git a/pages/Anterior Nasal Packing.md b/pages/Anterior Nasal Packing.md new file mode 100644 index 0000000..33a43e6 --- /dev/null +++ b/pages/Anterior Nasal Packing.md @@ -0,0 +1,6 @@ +# Indications #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67580766-5a39-4479-983a-f5613f19ffbd +- # Procedure #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758076f-ef20-4a33-9688-15305850c814 \ No newline at end of file diff --git a/pages/Anticoantral Chronic Suppurative Otitis Media.md b/pages/Anticoantral Chronic Suppurative Otitis Media.md index ff24d60..ad01fcd 100644 --- a/pages/Anticoantral Chronic Suppurative Otitis Media.md +++ b/pages/Anticoantral Chronic Suppurative Otitis Media.md @@ -1,70 +1,82 @@ -alias:: Anticoantral variety CSOM +alias:: Anticoantral variety CSOM, Unsafe variety of CSOM ICD-11_Code:: tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: f8d47a95-8dcc-438b-b36a-e4d1e6108f8c + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- # Characteristics of Discharge #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fc3a-4e53-4ebc-9629-14b8dd06e859 - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: c482bb3c-04fd-4000-9f1a-337441876d57 + - ##### Intracranial Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 686fe1fe-fdcf-416c-8dc1-6dc2ec404981 + - ##### Management of any one intracranial complications of CSOM #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fe99-6247-41fd-aeaa-1a73068239ed + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Antral Washout.md b/pages/Antral Washout.md index e1953da..ba93c2a 100644 --- a/pages/Antral Washout.md +++ b/pages/Antral Washout.md @@ -3,9 +3,12 @@ tags:: #[[Surgical Procedure]] - # Indications #ent-prof-card #unanswered #card deck:: #ENT id:: 6756c44b-7db9-4b7f-ae8b-176edf836f3a -- # Procedure #ent-prof-card #unanswered #card - deck:: #ENT +- # Procedure #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf36-daf0-4b1b-b27a-38bdfc1b2cbd + deck:: #ENT - # Complications #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf36-4a24-4d8f-b0ac-af31f3f3910a +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d4c-b2a6-4647-beb0-c1eef96a0e33 \ No newline at end of file diff --git a/pages/Apyrexial Laryngeal Stridor.md b/pages/Apyrexial Laryngeal Stridor.md new file mode 100644 index 0000000..9a7b019 --- /dev/null +++ b/pages/Apyrexial Laryngeal Stridor.md @@ -0,0 +1,6 @@ +# Causes #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6758148e-0885-4892-8610-ef6d4e505cc2 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581496-e5de-445e-afb0-d985e3cfd6ac \ No newline at end of file diff --git a/pages/Atrophic Rhinitis.md b/pages/Atrophic Rhinitis.md index 543e400..8e24a55 100644 --- a/pages/Atrophic Rhinitis.md +++ b/pages/Atrophic Rhinitis.md @@ -1,75 +1,81 @@ - alias:: ICD-11_Code:: tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675809f3-6032-49dc-a61b-75b648bb5f64 - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 076f87a1-3352-4223-ab92-057fa79dcb5c - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 6c359ab4-206d-4b36-ac9e-9ccef443bae6 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: cdac1bc9-1e05-45ba-8e84-2c8168f2a52c - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #unanswered #card + deck:: #ENT + id:: cdac1bc9-1e05-45ba-8e84-2c8168f2a52c + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580a39-cf56-4b0f-aed8-c22d29d68144 \ No newline at end of file diff --git a/pages/Branchial Cyst.md b/pages/Branchial Cyst.md new file mode 100644 index 0000000..0397cc1 --- /dev/null +++ b/pages/Branchial Cyst.md @@ -0,0 +1,77 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816b7-9859-4bc6-bc3d-d746c1d1ad9d +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: b0461cb4-85cd-4d1f-b38c-e0b364f85390 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816cb-502e-4950-a501-eba182f53e6b \ No newline at end of file diff --git a/pages/Carcinoma Larynx.md b/pages/Carcinoma Larynx.md index 2acc24f..97e1743 100644 --- a/pages/Carcinoma Larynx.md +++ b/pages/Carcinoma Larynx.md @@ -3,78 +3,81 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features (Glottis Stage-I) #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: e7ef8278-394b-4031-81a4-7ae527bf7f6f - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ba70-7690-4493-9769-4bb8d8576e1b - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ba70-7690-4493-9769-4bb8d8576e1b + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment(Glottis Stage-1) #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: f47ebcf7-3ddd-490a-ba70-306d4b3239be - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ##### Release a case of airway obstruction due to Carcinoma Larynx #ent-prof-card #unanswered #card deck:: #ENT id:: 6756baf9-e01b-4bb0-8058-c9b6f7e146f1 - - [[Tracheostomy]] + - [[Tracheostomy]] - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758153c-60f5-4a53-ad56-171ae794ed64 \ No newline at end of file diff --git a/pages/Cholesteatoma.md b/pages/Cholesteatoma.md index c44d380..7a8c929 100644 --- a/pages/Cholesteatoma.md +++ b/pages/Cholesteatoma.md @@ -1,84 +1,88 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756c713-60be-453c-8b30-ab4c6d5335e0 + deck:: #ENT - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease #ent-prof-card #unanswered #card - deck:: #ENT - id:: b4a881f1-bb60-4a39-8c4d-af04161a135e - - ### Affected Systems/Organs - - Intracranial Complications - - Mechanism #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ce3a-2ab7-4c2c-8a0a-1cc353422dd0 + - ### Mechanism of Disease #ent-prof-card #unanswered #card + deck:: #ENT + id:: b4a881f1-bb60-4a39-8c4d-af04161a135e + - ### Affected Systems/Organs + - Intracranial Complications + - Mechanism #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ce3a-2ab7-4c2c-8a0a-1cc353422dd0 - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 6756cf34-077e-4771-9169-584c3f362368 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: 74adc7e7-90e1-4f58-a18e-ac41a147949d + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 2e0078c6-cf6c-4b3d-8223-0ca14f393bf2 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: b23de92e-4657-4264-824c-24fa3cad1f05 - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #unanswered #card + id:: b23de92e-4657-4264-824c-24fa3cad1f05 + deck:: #ENT + - ##### Extracranial Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 26f0e9a1-f225-4e31-8f8c-6797e5c5d606 + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Chronic Maxillary Sinusitis.md b/pages/Chronic Maxillary Sinusitis.md index f00f9cb..0e52de6 100644 --- a/pages/Chronic Maxillary Sinusitis.md +++ b/pages/Chronic Maxillary Sinusitis.md @@ -1,75 +1,77 @@ - alias:: ICD-11_Code:: tags:: #Disease -- ## Etiology +- ## Etiology #ent-prof-written #unanswered #card background-color:: blue - - ### Causative Agents - - ### Risk Factors + deck:: #ENT + id:: 4593a649-7f04-4c18-9259-eda7a8f996e9 + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 2b3fabc1-bcd2-478c-9359-217b0ccfec52 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 1010e57a-e0f8-4c59-b704-25ab11c34937 - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 5f482ed7-2c91-4a3c-b7e2-a07a17eb328b - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Chronic Retropharyngeal Abscess.md b/pages/Chronic Retropharyngeal Abscess.md index 101a2aa..54aaf53 100644 --- a/pages/Chronic Retropharyngeal Abscess.md +++ b/pages/Chronic Retropharyngeal Abscess.md @@ -3,74 +3,77 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 25d8cef9-d646-4c62-a329-59dc6819cf92 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b622-96b5-44c0-8b11-0d31e5b0a86e - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b622-96b5-44c0-8b11-0d31e5b0a86e + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: b74bd004-ee30-4dd4-abc5-fa18e986569f - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758118c-3559-4253-97b5-4b3a4592b1f5 \ No newline at end of file diff --git a/pages/Chronic Suppurative Otitis Media.md b/pages/Chronic Suppurative Otitis Media.md index 41f71e1..3a0cf6a 100644 --- a/pages/Chronic Suppurative Otitis Media.md +++ b/pages/Chronic Suppurative Otitis Media.md @@ -4,83 +4,94 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - [[Tubotympanic Chronic Suppurative Otitis Media]] - - [[Anticoantral Chronic Suppurative Otitis Media]] - - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: e02ad0f3-b7ca-4c01-b24b-d23f02d1d618 + - [[Tubotympanic Chronic Suppurative Otitis Media]] + - [[Anticoantral Chronic Suppurative Otitis Media]] + - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef + - ### Diagnostic Criteria +- ### Differences between CSOM safe variety from unsafe variety #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fca8-097d-4e46-a639-851515f4c2f8 - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation - - deck:: #ENT - id:: 6756bff6-4066-4836-ad06-539a7077b1ca - |Test|Interpretation| - |[[Rinne's Test]]|{{c1 }}| - |[[Weber Test]]|{{c2 }}| - #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756bff6-4066-4836-ad06-539a7077b1ca - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation + - deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + |Test|Interpretation| + |[[Rinne's Test]]|{{c1 }}| + |[[Weber Test]]|{{c2 }}| + #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- # Management of a safe variety of CSOM in dry Stage #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fb4f-2585-4c30-90bc-5e207aac3091 - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fb69-04f9-42d1-b8e8-d8fb771044e9 \ No newline at end of file diff --git a/pages/Cochlear Implant.md b/pages/Cochlear Implant.md new file mode 100644 index 0000000..156d858 --- /dev/null +++ b/pages/Cochlear Implant.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580122-f481-4e5c-af10-a58169662bac \ No newline at end of file diff --git a/pages/Conductive Type of Hearing Loss.md b/pages/Conductive Type of Hearing Loss.md index f326cd6..e366ebe 100644 --- a/pages/Conductive Type of Hearing Loss.md +++ b/pages/Conductive Type of Hearing Loss.md @@ -1,11 +1,8 @@ -# Causes #ent-prof-card #unanswered #card - -deck:: #ENT -id:: 6756c805-79cd-468e-a5ae-78726b2f5f52 - -deck:: #ENT -id:: 6756c805-79cd-468e-a5ae-78726b2f5f52 +alias:: Conductive Deafness +- # Causes #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756c805-79cd-468e-a5ae-78726b2f5f52 - # Conductive Hearing Pathway #ent-prof-card #unanswered #card deck:: #ENT - id:: 6756cf38-b1a0-41d8-8382-ddef99b77ba1 + id:: 6756cf38-b1a0-41d8-8382-ddef99b77ba1 \ No newline at end of file diff --git a/pages/Congenital Neck Swelling.md b/pages/Congenital Neck Swelling.md new file mode 100644 index 0000000..1e8a1a6 --- /dev/null +++ b/pages/Congenital Neck Swelling.md @@ -0,0 +1,9 @@ +# Causes #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67581679-1891-44b3-a97f-60fadfbf6ee8 +- Differentiate from Other Neck Swellings #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581682-1900-4568-8ba2-88cb54d22358 +- # Surgical Management #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581695-ee26-4bfb-9b2b-450ea6b5c990 \ No newline at end of file diff --git a/pages/Cornea.md b/pages/Cornea.md index a2d7389..1e54d45 100644 --- a/pages/Cornea.md +++ b/pages/Cornea.md @@ -11,6 +11,8 @@ id:: 6755d348-2ba5-4418-b753-7d0d393bddce - Descemet's membrane (Posterior Limiting Lamina) logseq.order-list-type:: number + - Endothelium + logseq.order-list-type:: number - # Factors responsible for the transparency of Cornea #eye-prof-card #card deck:: #Eye id:: 6755d64e-9c2a-479d-be62-0751197354c1 diff --git a/pages/Corrosive Burn of Esophagus.md b/pages/Corrosive Burn of Esophagus.md new file mode 100644 index 0000000..14ca3ed --- /dev/null +++ b/pages/Corrosive Burn of Esophagus.md @@ -0,0 +1,3 @@ +# Treatment #ent-prof-written #unanswered #card +deck:: #ENT +id:: 675813f5-20c8-4d50-84d6-a6a5fa35170b \ No newline at end of file diff --git a/pages/Deviated Nasal Septum.md b/pages/Deviated Nasal Septum.md index 29e8ec2..38e3e36 100644 --- a/pages/Deviated Nasal Septum.md +++ b/pages/Deviated Nasal Septum.md @@ -5,71 +5,74 @@ background-color:: blue deck:: #ENT id:: a12b2c41-66a3-47f3-955c-f74a8fd201f4 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 54938744-188d-4ab1-aa09-32bef16d24a4 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 79b6dbbe-38f6-4e65-98ab-4b95f3dade21 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758081e-3bcc-4f03-8216-c0e7fccb3ecd \ No newline at end of file diff --git a/pages/Diptheria.md b/pages/Diptheria.md index 149fcd2..b10d27a 100644 --- a/pages/Diptheria.md +++ b/pages/Diptheria.md @@ -1,6 +1,7 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease +alias:: Faucal Diptheria +ICD-11_Code:: +tags:: #Disease + - ## Etiology background-color:: blue - ### Causative Agents @@ -32,8 +33,10 @@ - ### Imaging Studies - ### Differential Diagnosis - ### Confirmation of Diagnosis -- ## Management and Treatment +- ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue + deck:: #ENT + id:: 366399fd-5120-48a7-bf04-beaa7d657344 - ### Medical Treatment - ### Surgical Options - ### Lifestyle and Dietary Recommendations diff --git a/pages/Discharging Ear.md b/pages/Discharging Ear.md new file mode 100644 index 0000000..b06855c --- /dev/null +++ b/pages/Discharging Ear.md @@ -0,0 +1,5 @@ +tags:: #Signs + +- # Causes #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f9fe-b94e-413b-b022-7c4dbc6ae58f \ No newline at end of file diff --git a/pages/Dysphagia.md b/pages/Dysphagia.md index 98667af..58a8d67 100644 --- a/pages/Dysphagia.md +++ b/pages/Dysphagia.md @@ -1,7 +1,8 @@ -# Causes #ent-prof-card #unanswered #card - -deck:: #ENT +# Causes #ent-prof-card #ent-prof-written #unanswered #card id:: 6756ae7f-49cd-4dfb-8585-67c361d767ec - deck:: #ENT -id:: 6756ae7f-49cd-4dfb-8585-67c361d767ec + - Oropharyngeal Causes + - Esophageal Causes +- # Investigations #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581262-83ba-4c98-a8e1-a71e8892dbd2 \ No newline at end of file diff --git a/pages/ENT Question Summary.md b/pages/ENT Question Summary.md new file mode 100644 index 0000000..d24e38d --- /dev/null +++ b/pages/ENT Question Summary.md @@ -0,0 +1,6 @@ +- Written = 259 +- Viva = 264 +- Both = 85 +- Total = 438 +- Only Written = 176 +- Only Viva = 182 \ No newline at end of file diff --git a/pages/Enlarged Adenoid.md b/pages/Enlarged Adenoid.md index b8d4064..82a0ef1 100644 --- a/pages/Enlarged Adenoid.md +++ b/pages/Enlarged Adenoid.md @@ -1,14 +1,83 @@ -# Consequences (in child) #ent-prof-card #unanswered #card +alias:: Adenoid -deck:: #ENT -id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 - -deck:: #ENT -id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 - -- # Correction/Treatment #ent-prof-card #unanswered #card +- #definition {{c1 }} #ent-prof-written #unanswered #card deck:: #ENT - id:: 6756cf30-222b-4dce-8e35-4a8fc615ffe1 -- # Clinical Features of Adenoid Facies #ent-prof-card #unanswered #card + id:: 67580de0-f75a-494a-9860-2edd42814113 +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue deck:: #ENT + id:: ebea0a07-c8e9-495a-bcf6-ed94e5f1e3a8 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- # Clinical Features of Adenoid Facies #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf30-0e89-4438-8dbb-5f4e1ed28c63 + deck:: #ENT +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigations #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580e87-164e-4437-9d0d-cc738924bf3c + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- # Correction/Treatment #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf30-222b-4dce-8e35-4a8fc615ffe1 + deck:: #ENT +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - ((6756b219-4c90-4cd6-9ad0-94a78e34ae37)) + - #### Without Treatment + - ##### Consequences (in child) #ent-prof-card #unanswered #card + id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 + deck:: #ENT + deck:: #ENT + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ebb-8cdb-4b69-b32d-1cc4df492e16 \ No newline at end of file diff --git a/pages/Epistaxis.md b/pages/Epistaxis.md index 70b056b..5793349 100644 --- a/pages/Epistaxis.md +++ b/pages/Epistaxis.md @@ -1,108 +1,114 @@ - alias:: ICD-11_Code:: tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758071c-d00d-437c-8f79-775a56513681 - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6733ccec-688c-4457-840d-2ffaa6f77b4b - - ### Risk Factors - - | Most Commons | Coagulopathy | Inflammatory | Iatrogenic(medication induced) | Neoplastic | Traumatic | Vascular | - | ---------------------------------- | --------------------------- | -------------------------------------------------- | -------------------------------------------- | ------------------------ | ------------------------------------------ | ----------------------------------------------------------------- | - | Nose Picking (most common) | Thrombocytopenia (ITP, TTP) | Granulomatosis with polyangitis (GPA or Wegener's) | Anticoagulation (warfarin, heparin, etc) | Sq. C. C | Anatomical deformities (e.g. septal spurs) | Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) | - | foreign object (children) | Von Willebrand's Disease | SLE | Insufflated drugs (particularly cocaine) | Melanoma | Blunt trauma (e.g. a punch in the face) | carotid artery aneurysm | - | blunt trauma (MVA) | Hemophilia | | Nasal sprays (nasal steroids: prolonged use) | Adenoid Cystic Carcinoma | Foreign bodies (or nose picking) | Angioma | - | RTIs (chronic sinusitis, rhinitis) | Leukemia | | | Nasopharyngeal carcinoma | Nasal bone fracture | Anigofibroma | + - ### Causative Agents #ent-prof-card #ent-prof-written #unanswered #card + id:: 6733ccec-688c-4457-840d-2ffaa6f77b4b + deck:: #ENT + - Local Causes + - ... + - ... + - ### Risk Factors + - | Most Commons | Coagulopathy | Inflammatory | Iatrogenic(medication induced) | Neoplastic | Traumatic | Vascular | + | ---------------------------------- | --------------------------- | -------------------------------------------------- | -------------------------------------------- | ------------------------ | ------------------------------------------ | ----------------------------------------------------------------- | + | Nose Picking (most common) | Thrombocytopenia (ITP, TTP) | Granulomatosis with polyangitis (GPA or Wegener's) | Anticoagulation (warfarin, heparin, etc) | Sq. C. C | Anatomical deformities (e.g. septal spurs) | Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) | + | foreign object (children) | Von Willebrand's Disease | SLE | Insufflated drugs (particularly cocaine) | Melanoma | Blunt trauma (e.g. a punch in the face) | carotid artery aneurysm | + | blunt trauma (MVA) | Hemophilia | | Nasal sprays (nasal steroids: prolonged use) | Adenoid Cystic Carcinoma | Foreign bodies (or nose picking) | Angioma | + | RTIs (chronic sinusitis, rhinitis) | Leukemia | | | Nasopharyngeal carcinoma | Nasal bone fracture | Anigofibroma | - ## Epidemiology background-color:: blue - - ### Incidence - - A bimodal age distribution - - most commonly affecting those: - - younger than 10 and - logseq.order-list-type:: number - - older than 50 - logseq.order-list-type:: number - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - A bimodal age distribution + - most commonly affecting those: + - younger than 10 and + logseq.order-list-type:: number + - older than 50 + logseq.order-list-type:: number + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - blood coming out of the nostrils - - blood coming out of the lacrimal ducts (shedding tears of blood) - - blood coming out of the mouth (vomiting) - - blood coming out of the anus(with stool... Very rare(dark blood because it has passed by the stomach acid) - - blood is cathartic -> diarrhea - - rule of thumb: blood is [[Cathartic]] whereas iron is constipating - - #### Signs - - ### Types - - Anterior Epistaxis - - Posterior Epitaxis - - #### Differences between ((6708e6ef-4496-4512-8dec-a10fa7e9b655)) and ((6708e6f5-25c3-4bfe-8839-db3a63ee7ac1)) - - | Posterior Epistaxis | Anterior Epistaxis | - | ------------------- | -------------------------------------- | - | Less Common | More Common | - | Older Patient | Younger Patient | - | HTN | Mucosal Dryness/ Foreign Body/ Picking | - | More Significant | Less Significant | - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - blood coming out of the nostrils + - blood coming out of the lacrimal ducts (shedding tears of blood) + - blood coming out of the mouth (vomiting) + - blood coming out of the anus(with stool... Very rare(dark blood because it has passed by the stomach acid) + - blood is cathartic -> diarrhea + - rule of thumb: blood is [[Cathartic]] whereas iron is constipating + - #### Signs + - ### Types + - Anterior Epistaxis + - Posterior Epitaxis + - #### Differences between ((6708e6ef-4496-4512-8dec-a10fa7e9b655)) and ((6708e6f5-25c3-4bfe-8839-db3a63ee7ac1)) + - | Posterior Epistaxis | Anterior Epistaxis | + | ------------------- | -------------------------------------- | + | Less Common | More Common | + | Older Patient | Younger Patient | + | HTN | Mucosal Dryness/ Foreign Body/ Picking | + | More Significant | Less Significant | + - ### Diagnostic Criteria - ## Diagnosis & Treatment background-color:: blue - - Child -> picking his nose -> bleeding from anterior septum -> local pressure and phenylephrine spray will save the day [+antrior packing if severe] - logseq.order-list-type:: number - - Youth/young adult -> cocaine (will perforate the nasal septum) -> posterior packing "mnemonic: cocaine comes in packages, so you should pack the nose" - logseq.order-list-type:: number - - Youth/young adult -> [[juvenile nasopharyngeal angiofibroma]] -> surgical resection is a MUST "mnemonic: oma means mass, and you should remove it" - logseq.order-list-type:: number - collapsed:: true - - eventhough [[angiofibroma]] is a benign tumor (not cancer), it eats and erodes the surrounding structure - - {{query #benign_but_eroding}} - query-table:: true - - Elderly Hypertensive -> Huge amount of bleeding [life threatening] -> BP controlling, posterior packing and vessel ligation - logseq.order-list-type:: number - - Hemorrhages that are life-threatening occur in the posterior segment (sphenopalatine artery, a branch of maxillary artery) - - Common causes include foreign body, trauma, allergic rhinitis, and nasal angiofibromas (common in adolescent males) + - Child -> picking his nose -> bleeding from anterior septum -> local pressure and phenylephrine spray will save the day [+antrior packing if severe] + logseq.order-list-type:: number + - Youth/young adult -> cocaine (will perforate the nasal septum) -> posterior packing "mnemonic: cocaine comes in packages, so you should pack the nose" + logseq.order-list-type:: number + - Youth/young adult -> [[Juvenile Nasopharyngeal Angiofibroma]] -> surgical resection is a MUST "mnemonic: oma means mass, and you should remove it" + logseq.order-list-type:: number + collapsed:: true + - eventhough [[angiofibroma]] is a benign tumor (not cancer), it eats and erodes the surrounding structure + - {{query #benign_but_eroding}} + query-table:: true + - Elderly Hypertensive -> Huge amount of bleeding [life threatening] -> BP controlling, posterior packing and vessel ligation + logseq.order-list-type:: number + - Hemorrhages that are life-threatening occur in the posterior segment (sphenopalatine artery, a branch of maxillary artery) + - Common causes include foreign body, trauma, allergic rhinitis, and nasal angiofibromas (common in adolescent males) - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 6733ccec-105f-48ff-ba7c-1b3af590ed12 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Complications background-color:: blue - - ### Possible Complications - - ### Long-term Effects + - ### Possible Complications + - ### Long-term Effects - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Esophageal Perforation.md b/pages/Esophageal Perforation.md index ed8dc7f..83775c6 100644 --- a/pages/Esophageal Perforation.md +++ b/pages/Esophageal Perforation.md @@ -3,69 +3,71 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: 166d4481-f608-4cdf-b3e8-e06ddc40f105 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 1e979a08-37ac-4cd4-934f-370c1fd01f0b - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Esophagoscopy.md b/pages/Esophagoscopy.md index ef907d5..51260fb 100644 --- a/pages/Esophagoscopy.md +++ b/pages/Esophagoscopy.md @@ -1,7 +1,12 @@ -# Complications develed during Esophagoscopy or removal of FB esophagus #ent-prof-card #unanswered #card - -deck:: #ENT - [[Esophageal Perforation]] -id:: 6756acf1-135a-4bde-8774-96fb02071d8f - -deck:: #ENT - [[Esophageal Perforation]] +# Complications developed during Esophagoscopy or removal of FB esophagus #ent-prof-card #ent-prof-written #unanswered #card id:: 6756acf1-135a-4bde-8774-96fb02071d8f +deck:: #ENT + - Rigid Esophagoscopy + - [[Esophageal Perforation]] + - Most Dangerous -> {{c2 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581305-b231-4658-b6f4-18d0fa4702b6 +- Treatment of most..dangerous complication..... #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581316-b3ff-4fd7-87d1-8cd45ba68956 +- [[Dysphagia]] \ No newline at end of file diff --git a/pages/Esophagus.md b/pages/Esophagus.md new file mode 100644 index 0000000..d1a85bc --- /dev/null +++ b/pages/Esophagus.md @@ -0,0 +1 @@ +- [[Mechanism of Swallowing]] \ No newline at end of file diff --git a/pages/Ethmoidal Polyp.md b/pages/Ethmoidal Polyp.md index 1a6945b..a283f3e 100644 --- a/pages/Ethmoidal Polyp.md +++ b/pages/Ethmoidal Polyp.md @@ -1,77 +1,81 @@ - alias:: ICD-11_Code:: tags:: #Disease -- ## Etiology +- ## Etiology #ent-prof-written #unanswered #card background-color:: blue - - ### Causative Agents - - ### Risk Factors + deck:: #ENT + id:: dc456351-714f-49d5-a834-6143be3783b1 + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: f4d8d22c-b143-42ca-a55d-287f6d874f75 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 146ed908-262b-45bb-a3c9-ee89813aaaa7 - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Antrochoanal Polyp]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756c3ac-94e0-4b01-9b59-15fa3ea7206c - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Antrochoanal Polyp]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c3ac-94e0-4b01-9b59-15fa3ea7206c + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 191b8483-4607-4bb9-821e-207baa7e562c - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Eustachian Tube.md b/pages/Eustachian Tube.md index 7391cea..16448f3 100644 --- a/pages/Eustachian Tube.md +++ b/pages/Eustachian Tube.md @@ -1,11 +1,11 @@ alias:: Auditory Tube -- # Anatomy #ent-prof-card #unanswered #card - deck:: #ENT +- # Anatomy #ent-prof-card #ent-prof-written #unanswered #card id:: 6756bf1c-4c53-495a-841d-5e1e2ddcfff9 -- # Physiology #ent-prof-card #unanswered #card deck:: #ENT +- # Physiology #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf31-1739-429c-b82b-5c7d200113a9 + deck:: #ENT - # Causes of Eustachian Tube Dysfunction #ent-prof-card #unanswered #card deck:: #ENT - id:: 6756cf31-083e-4ee2-8fb8-e8afa7ba9bbd + id:: 6756cf31-083e-4ee2-8fb8-e8afa7ba9bbd \ No newline at end of file diff --git a/pages/Foreign Body in Ear.md b/pages/Foreign Body in Ear.md index 8ec7057..5834468 100644 --- a/pages/Foreign Body in Ear.md +++ b/pages/Foreign Body in Ear.md @@ -1,4 +1,4 @@ -# Types #ent-prof-card #card #[[External Ear]] +# Types #ent-prof-card #ent-prof-written #card #[[External Ear]] id:: 6756a934-1410-48f2-b1a9-99cdf6a75c0c deck:: #ENT - Nonliving @@ -33,7 +33,7 @@ deck:: #ENT logseq.order-list-type:: number - maggots from flies logseq.order-list-type:: number -- # Management of a case of Living Body in ear #ent-prof-card #card #[[External Ear]] +- # Management of a case of Living Body in ear #ent-prof-card #ent-prof-written #card #[[External Ear]] id:: 6756cf39-f53f-48c4-b651-e41c2953306b deck:: #ENT - No attempt should be made to catch them alive @@ -47,4 +47,7 @@ deck:: #ENT - Syrining - Suction - Microscopic removal with special instruments - - Postaural approach \ No newline at end of file + - Postaural approach +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f761-f508-45ac-86a6-33c2821188c7 \ No newline at end of file diff --git a/pages/Foreign Body in Esophagus.md b/pages/Foreign Body in Esophagus.md index 980c3fe..644e9c3 100644 --- a/pages/Foreign Body in Esophagus.md +++ b/pages/Foreign Body in Esophagus.md @@ -3,74 +3,83 @@ tags:: #Disease - ## Etiology background-color:: blue - - # Common Foreign Bodies that may introduced in the Oesophagus #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b3d0-6307-466a-a856-af9b4a6ef67c - - ### Causative Agents - - ### Risk Factors + - ## Common Foreign Bodies that may introduced in the Oesophagus #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b3d0-6307-466a-a856-af9b4a6ef67c + deck:: #ENT + - In oldage + - ## Where are the esophageal Foreign Body found commonly #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581348-bcd7-4fa6-bb26-526d2e32d786 + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: fcaf4274-5a62-4051-bb53-6838993f76b1 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 6dfa3abe-e61f-4f44-bf88-55cc2d38780e - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: b42c502a-a704-4ce8-a75c-694ca18e15b0 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758138c-9ac2-4045-89ea-9389dde02a04 \ No newline at end of file diff --git a/pages/Foreign Body in Larynx.md b/pages/Foreign Body in Larynx.md index cd01f68..c832b10 100644 --- a/pages/Foreign Body in Larynx.md +++ b/pages/Foreign Body in Larynx.md @@ -3,71 +3,71 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 52956cb8-b56e-4fa6-afcb-a8c6b2693452 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 41b76876-2a54-446b-97b6-537746e31f1d - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Foreign Body in Nose.md b/pages/Foreign Body in Nose.md index 2780b45..531ef3b 100644 --- a/pages/Foreign Body in Nose.md +++ b/pages/Foreign Body in Nose.md @@ -3,74 +3,77 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Names of Foreign Bodies in Nose #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756c608-aef3-4c0d-a3a3-ecc8abd74751 - - ### Risk Factors + - ### Causative Agents + - ### Names of Foreign Bodies in Nose #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c608-aef3-4c0d-a3a3-ecc8abd74751 + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 2825038c-36a6-4d14-bc37-11cff7ba062a - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 75f55c1e-b022-41f2-864f-518b3d6e6db5 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580948-5e8e-43cf-b726-b358427d9d85 \ No newline at end of file diff --git a/pages/Functional Endoscopic Sinus Surgery.md b/pages/Functional Endoscopic Sinus Surgery.md index 0ce3fcb..cfa2ace 100644 --- a/pages/Functional Endoscopic Sinus Surgery.md +++ b/pages/Functional Endoscopic Sinus Surgery.md @@ -1,9 +1,15 @@ alias:: FESS tags:: #[[Surgical Procedure]] -- # Indications #ent-prof-card #unanswered #card +- #definition {{c1 }} #ent-prof-written #unanswered #card deck:: #ENT + id:: 67580cd6-321f-49d8-8ff0-ab27e721a78c +- # Indications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756bc61-818f-48fa-bfcc-07b3c2f7d429 -- # Complications #ent-prof-card #unanswered #card deck:: #ENT +- # Complications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf38-c69d-4a54-ac79-21ddb2e7b4bf + deck:: #ENT +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d41-b5bd-436b-b1b2-a8d630eacf9a \ No newline at end of file diff --git a/pages/Furunculosis.md b/pages/Furunculosis.md index 3d21524..712f7db 100644 --- a/pages/Furunculosis.md +++ b/pages/Furunculosis.md @@ -1,13 +1,16 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease -- #definition {{c1 Recurrent or multiple [[Furuncle]]s is called Furunculosis }} #ent-prof-card #unanswered #card - id:: 6756a8ab-4837-43bd-8f2a-5e5a48df80fa +alias:: Localized Acute Otitis Externa +ICD-11_Code:: +tags:: #Disease + +- #definition {{c1 A furuncle is a staphylococcal infection of the hair follicle of the outer 1/3rd of the external ear}} #ent-prof-card #card #[[External Ear]] + id:: 67579687-462c-4d72-a007-b7aabc820878 deck:: #ENT - ## Etiology background-color:: blue - id:: 6756cf33-62f1-4697-b808-6abef9e42e55 - - ### Causative Agents + - ### Causative Agents #ent-prof-card #card #[[External Ear]] + deck:: #ENT + id:: c3ed9276-100a-4ae9-8b22-5374b5db6310 + - [[Staphylococcus aureus]] - ### Risk Factors - ## Epidemiology background-color:: blue @@ -15,16 +18,18 @@ - ### Prevalence - ### Demographics - ### Geographic Distribution -- ## Pathophysiology #ent-prof-card #unanswered #card +- ## Pathophysiology #ent-prof-card #card #[[External Ear]] background-color:: blue deck:: #ENT - id:: f0515a7d-e1eb-4340-981b-5b843b5bb246 + id:: bcf7efa7-463f-4fe6-af30-cee75433b2ed - ### Mechanism of Disease + - infection of the hair follicles of external ear by [[Staphylococcus aureus]] - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - only the cartilagenous part comprises the hair follicles, hence Furuncle is confined to cartilagenous part of external ear +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT - id:: e445fb66-0f09-4bbf-a956-f1602db091af + id:: 4c306545-036f-47cd-920c-f0c4f03dc15c - ### Signs and Symptoms - #### Symptoms - #### Signs @@ -39,13 +44,24 @@ - ### Imaging Studies - ### Differential Diagnosis - ### Confirmation of Diagnosis -- ## Management and Treatment +- ## Management and Treatment #ent-prof-card #card #[[External Ear]] background-color:: blue - id:: 0103a3c3-347d-4f75-8dfc-57f0e330cc30 + deck:: #ENT + id:: 3af07f85-c7db-408f-a49b-e78a42fe5ebd - ### Medical Treatment + - Systemic Antibiotics + - Analgesics + - Local Heat + - Ear pack of 10% ichthammol glycerine provides splintage and reduces pain + - Hygroscopic action of glycerine reduces oedema + - ichammol is mildly antiseptic - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + if abscess formed + - incision and drainage of abscess + - If recurrent [[Furunculosis]] + - Exclude diabetes + - Attention paid to the patient's nasal vestibules which may harbour staphylococci and the infection transferred by patient's fingers + - Staphylococcal infections of the skin as a possible source should also be excluded and suitably treated - ## Prognosis background-color:: blue - ### Expected Course diff --git a/pages/Impedance Audiogram.md b/pages/Impedance Audiogram.md new file mode 100644 index 0000000..0cce5e4 --- /dev/null +++ b/pages/Impedance Audiogram.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580575-9992-4646-9d82-3e223fe3f083 \ No newline at end of file diff --git a/pages/Lateral Neck Swelling.md b/pages/Lateral Neck Swelling.md new file mode 100644 index 0000000..2f23cc8 --- /dev/null +++ b/pages/Lateral Neck Swelling.md @@ -0,0 +1,9 @@ +tags:: #Signs +contrast:: [[Midline Neck Swelling]] + +- # Differential Diagnosis #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b738-5c13-460d-9a96-9707e47a3ff4 + deck:: #ENT +- # Investigations #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758166a-07fd-4ca2-989f-cf5d7ca058f2 \ No newline at end of file diff --git a/pages/Littles Area.md b/pages/Littles Area.md index d027005..21bcb14 100644 --- a/pages/Littles Area.md +++ b/pages/Littles Area.md @@ -1,9 +1,12 @@ -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756bcc7-fbf8-411d-b48f-312a50249833 -- # Formation #ent-prof-card #unanswered #card deck:: #ENT +- # Formation #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf35-c282-4bea-a8d4-b1ba0552c3e1 -- # Clinical Importance #ent-prof-card #unanswered #card deck:: #ENT +- # Clinical Importance #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf35-249b-42d1-853d-a57a518fa977 + deck:: #ENT +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580700-cfda-4772-a1cf-33c6109c5cd9 \ No newline at end of file diff --git a/pages/Ludwig's Angina.md b/pages/Ludwig's Angina.md index cafc3c3..b9661f5 100644 --- a/pages/Ludwig's Angina.md +++ b/pages/Ludwig's Angina.md @@ -6,69 +6,72 @@ id:: 6756b8b1-7ab0-4520-b4a3-4cda026d234c - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: bde4b4a6-a339-4cd2-8e9a-5718408a868d - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758158a-e90c-4bef-bd9c-7ecac5e0e50f \ No newline at end of file diff --git a/pages/Mastoid Abscess.md b/pages/Mastoid Abscess.md new file mode 100644 index 0000000..ced32e1 --- /dev/null +++ b/pages/Mastoid Abscess.md @@ -0,0 +1,76 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differentiate #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f854-6d93-4975-9e3c-2d16ad361ffb + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f861-7242-4f50-9e37-e8f431f7acb9 \ No newline at end of file diff --git a/pages/Mastoidectomy.md b/pages/Mastoidectomy.md index d641cdd..8c1e52b 100644 --- a/pages/Mastoidectomy.md +++ b/pages/Mastoidectomy.md @@ -1,7 +1,19 @@ -# Types #ent-prof-card #unanswered #card - -deck:: #ENT - indications of different types - [[Modified Radical Mastoidectomy]] -id:: 6756c778-bb1a-42e6-bb4c-72b8d6d8cece - -deck:: #ENT - indications of different types - [[Modified Radical Mastoidectomy]] -id:: 6756c778-bb1a-42e6-bb4c-72b8d6d8cece +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805a6-3211-4260-9ca9-54cda3217df9 +- # Types #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756c778-bb1a-42e6-bb4c-72b8d6d8cece + deck:: #ENT +- # Aims #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805ed-471e-4652-9259-b4964ea64a14 +- # Indications of Different Types of Mastoidectomy #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758061e-8971-4017-b83c-9a3e05e54183 +- # Complication #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805be-d972-4904-9e77-546bf17e5707 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580655-70fe-4807-b22f-f0deeb621cb5 +- \ No newline at end of file diff --git a/pages/Mastoiditis.md b/pages/Mastoiditis.md new file mode 100644 index 0000000..2ba5a0d --- /dev/null +++ b/pages/Mastoiditis.md @@ -0,0 +1,72 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580006-6677-4b7b-a2d3-9a51269dde8d +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue \ No newline at end of file diff --git a/pages/Mechanism of Swallowing.md b/pages/Mechanism of Swallowing.md new file mode 100644 index 0000000..85c27c9 --- /dev/null +++ b/pages/Mechanism of Swallowing.md @@ -0,0 +1,3 @@ +- Discuss Mechanism of Swallowing #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675811b0-59d3-40e1-9a3c-3e029daa565e \ No newline at end of file diff --git a/pages/Meniere's Disease.md b/pages/Meniere's Disease.md index 9f145c5..7c43a6f 100644 --- a/pages/Meniere's Disease.md +++ b/pages/Meniere's Disease.md @@ -1,76 +1,79 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756c23f-2e59-47e9-b177-c10af5c95e12 + deck:: #ENT - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: cacace2a-0212-4b4f-8198-80c2164bb44f - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 3abf9902-4436-4be6-ad4c-1ad09cab3a65 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675800ff-fe62-48ff-98ef-df6ef1e4aa43 \ No newline at end of file diff --git a/pages/Middle Ear.md b/pages/Middle Ear.md index 72be454..a79a82b 100644 --- a/pages/Middle Ear.md +++ b/pages/Middle Ear.md @@ -5,10 +5,15 @@ id:: 6756bf03-cd24-4f3f-8bab-c176ca1ed123 deck:: #ENT id:: 6756bf03-cd24-4f3f-8bab-c176ca1ed123 - - # Contents #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf35-b68a-4b22-b7f1-06b40dce75b8 -- # Routes of Spread of Infection from middle ear to intracranium. #ent-prof-card #unanswered #card +- # Description of Medial wall of middle ear cavity with diagram #ent-prof-written #unanswered #card #unanswered + deck:: #ENT + id:: 6757f634-5f6a-47b5-8e16-f0d15354b740 +- # Drawing and Labelling medial wall of middle ear #ent-prof-written #unanswered #card + id:: 6757f663-3d94-4df3-93b2-8739de4f4584 deck:: #ENT +- # Routes of Spread of Infection from middle ear to intracranium. #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf35-4068-4493-8d99-33853a2e5002 + deck:: #ENT \ No newline at end of file diff --git a/pages/Midline Neck Swelling.md b/pages/Midline Neck Swelling.md index 07575e0..71176c3 100644 --- a/pages/Midline Neck Swelling.md +++ b/pages/Midline Neck Swelling.md @@ -1,5 +1,5 @@ tags:: #Signs -- # Differential Diagnosis #ent-prof-card #unanswered #card - deck:: #ENT +- # Differential Diagnosis #ent-prof-card #ent-prof-written #unanswered #card id:: 6756b84c-3be8-42c4-9daf-2bb01cb6bd0d + deck:: #ENT \ No newline at end of file diff --git a/pages/Multiple Papilloma of Larynx.md b/pages/Multiple Papilloma of Larynx.md index a077dce..424a03b 100644 --- a/pages/Multiple Papilloma of Larynx.md +++ b/pages/Multiple Papilloma of Larynx.md @@ -3,69 +3,74 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: 59f69b52-7bf6-43ba-b5b6-1d93d37f677b + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 042c3d7d-5137-411a-9c18-72e8dc5973c7 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: Inverted Papilloma #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758152f-13ba-497e-a307-a1b2a2605320 \ No newline at end of file diff --git a/pages/Myringoplasty.md b/pages/Myringoplasty.md new file mode 100644 index 0000000..4a61603 --- /dev/null +++ b/pages/Myringoplasty.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580581-9ea8-462a-9f67-1e27ec9ca67a \ No newline at end of file diff --git a/pages/Myringotomy.md b/pages/Myringotomy.md new file mode 100644 index 0000000..665abe3 --- /dev/null +++ b/pages/Myringotomy.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580589-6a65-4393-9e78-e600770e0bc3 \ No newline at end of file diff --git a/pages/Nasal Discharge.md b/pages/Nasal Discharge.md new file mode 100644 index 0000000..c75c7d2 --- /dev/null +++ b/pages/Nasal Discharge.md @@ -0,0 +1,7 @@ +tags:: #Signs + +- # Causes #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580790-e6e4-46c2-8bc7-24227408829f + - Unilateral + - Bilateral \ No newline at end of file diff --git a/pages/Nasal Obstruction.md b/pages/Nasal Obstruction.md index 4560dff..e0e2aa6 100644 --- a/pages/Nasal Obstruction.md +++ b/pages/Nasal Obstruction.md @@ -1,11 +1,6 @@ -# Causes of Unilateral Nasal Obstruction #ent-prof-card #unanswered #card - +# Causes of Nasal Obstruction #ent-prof-card #ent-prof-written #unanswered #card deck:: #ENT -id:: 6756bd03-b273-4585-82ec-5de64f8c9d53 - -deck:: #ENT -id:: 6756bd03-b273-4585-82ec-5de64f8c9d53 - -- # Causes of Bilateral Nasal Obstruction #ent-prof-card #unanswered #card +id:: 675807c7-eb5f-4e7d-b503-500b7e64afea +- # Management of a case of unilateral nasal obstruction #ent-prof-written #unanswered #card deck:: #ENT - id:: 6756cf32-efce-4a4f-8566-d27168a70380 + id:: 675807e8-64c2-424f-84c8-099bf776531c \ No newline at end of file diff --git a/pages/Nasal Polyp.md b/pages/Nasal Polyp.md index 128ec6e..9c70bc8 100644 --- a/pages/Nasal Polyp.md +++ b/pages/Nasal Polyp.md @@ -1,86 +1,90 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition soft tissue masses (teardrop-shaped, non-neoplastic) that arises from the mucous membranes of the nose and paranasal sinuses. #ent-prof-card #unanswered #card - deck:: #ENT +- #definition soft tissue masses (teardrop-shaped, non-neoplastic) that arises from the mucous membranes of the nose and paranasal sinuses. #ent-prof-card #ent-prof-written #unanswered #card id:: 6733ccee-38eb-4cfd-b655-5edb891d4701 -- ## Etiology + deck:: #ENT +- ## Etiology #ent-prof-written #unanswered #card background-color:: blue - - ### Causative Agents - - ### Risk Factors - - In adults: commonly associated w/allergic rhinitis (IgE-mediated) -> mast cell degranulation) - - In kids: it's NOT allergic -> suspect cystic fibrosis - - cystic fibrosis -> thick secretions -> inflammatory nasal polyps (chronic inflammation) + deck:: #ENT + id:: 0e7442e6-ad9b-4003-ba04-01aa2148a661 + - ### Causative Agents + - ### Risk Factors + - In adults: commonly associated w/allergic rhinitis (IgE-mediated) -> mast cell degranulation) + - In kids: it's NOT allergic -> suspect cystic fibrosis + - cystic fibrosis -> thick secretions -> inflammatory nasal polyps (chronic inflammation) - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - Most common in adults: 40 years or older - - Male > female - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - Most common in adults: 40 years or older + - Male > female + - ### Geographic Distribution - Bilateral (usually) - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - usually due to chronic inflmmation - - ### Affected Systems/Organs + - ### Mechanism of Disease + - usually due to chronic inflmmation + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - History of [[Samter's triad]] - - #### Signs - - ### Stages or Classification #ent-prof-card #unanswered #card - deck:: #ENT - id:: a3130458-2726-4c0b-9ebd-085ec2810978 - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - History of [[Samter's triad]] + - #### Signs + - ### Stages or Classification #ent-prof-card #ent-prof-written #unanswered #card + id:: a3130458-2726-4c0b-9ebd-085ec2810978 + deck:: #ENT + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Inferior Turbinate]] - - Differentiate #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756beab-f1ec-4c13-95d1-2ac4ef1b90f1 - - ### Confirmation of Diagnosis -- ## Management and Treatment + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Inferior Turbinate]] + - Differentiate #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756beab-f1ec-4c13-95d1-2ac4ef1b90f1 + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + id:: 7eeb2f81-e618-47c8-9a84-7566854a35c4 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Nasal Septum.md b/pages/Nasal Septum.md index 6283290..993bf0f 100644 --- a/pages/Nasal Septum.md +++ b/pages/Nasal Septum.md @@ -5,8 +5,10 @@ id:: 6756bca9-74c8-443b-8071-33282805d64f deck:: #ENT id:: 6756bca9-74c8-443b-8071-33282805d64f - -- # Blood Supply #ent-prof-card #unanswered #card - deck:: #ENT +- # Blood Supply #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf38-6d8c-4d69-a647-fe6d82ad218c + deck:: #ENT - [[Littles Area]] +- # Drawing and Labelling the Nasal Septum #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580664-ea17-44ab-90a2-53eb99be67ba \ No newline at end of file diff --git a/pages/Neck Swelling.md b/pages/Neck Swelling.md deleted file mode 100644 index 569412e..0000000 --- a/pages/Neck Swelling.md +++ /dev/null @@ -1,6 +0,0 @@ -tags:: #Signs - -- # Differential Diagnosis #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b738-5c13-460d-9a96-9707e47a3ff4 -- [[Midline Neck Swelling]] diff --git a/pages/Nose.md b/pages/Nose.md index b8d39db..7ee21c8 100644 --- a/pages/Nose.md +++ b/pages/Nose.md @@ -1,5 +1,9 @@ # Function #ent-prof-card #unanswered #card - id:: 6756bce7-9deb-455d-a154-f47b658dd652 - -- ## deck:: #ENT +deck:: #ENT +- # Protective Functions of Nose #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675806a3-1ca4-4f91-aeaf-3c6df7891042 +- # Autonomic Nerve Supply of Nose and [[Paranasal Sinuses]] #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675806ba-ab33-4b4a-9aeb-4ea731da131c \ No newline at end of file diff --git a/pages/Ocular Chemical Injury.md b/pages/Ocular Chemical Injury.md index 78d8387..b92b606 100644 --- a/pages/Ocular Chemical Injury.md +++ b/pages/Ocular Chemical Injury.md @@ -1,11 +1,11 @@ # Complications #eye-prof-card #card id:: 6755f373-b8fc-4a44-aec6-5cdbf7cfcdc2 deck:: #Eye + - [[Symblepharon]] + logseq.order-list-type:: number - [[Corneal Opacity]] logseq.order-list-type:: number - [[Corneal Ulcer]] logseq.order-list-type:: number - [[Panopthalmitis]] - logseq.order-list-type:: number - - [[Symblepharon]] logseq.order-list-type:: number \ No newline at end of file diff --git a/pages/Ostosclerosis.md b/pages/Ostosclerosis.md index 6a629bd..ad95f66 100644 --- a/pages/Ostosclerosis.md +++ b/pages/Ostosclerosis.md @@ -8,71 +8,74 @@ background-color:: blue deck:: #ENT id:: 6756cf3a-1a9f-4d2a-a472-b8758ec4dc5e - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: b3dc5b3d-6350-4a81-99c5-6eace147331c - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 50b4d3aa-2afc-4659-8402-a810ca1e5960 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN : #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ffc3-f24d-4947-9bc6-4ec09ec9e26b \ No newline at end of file diff --git a/pages/Otitis Externa.md b/pages/Otitis Externa.md index 81ddbeb..210f77a 100644 --- a/pages/Otitis Externa.md +++ b/pages/Otitis Externa.md @@ -1,22 +1,34 @@ -# Classification #ent-prof-card #card #[[External Ear]] +# Classification #ent-prof-card #ent-prof-written #card #[[External Ear]] id:: 6756a805-64ab-44e4-aee0-a28c733812b3 deck:: #ENT - [[Malignant Otitis Externa]] - [[Diffuse Otitis Externa]] - Infective Group logseq.order-list-type:: number - - [[Furuncle]] + - Bacterial logseq.order-list-type:: number - - [[Diffuse Otitis Externa]] + - [[Diffuse Otitis Externa]] + logseq.order-list-type:: number + - [[Malignant Otitis Externa]] + logseq.order-list-type:: number + - [[Furunculosis]] + logseq.order-list-type:: number + - [[Lupus Vulgaris]] + logseq.order-list-type:: number + - Viral logseq.order-list-type:: number - - [[Malignant Otitis Externa]] + - [[Herpes Zoster Oticus]] + logseq.order-list-type:: number + - Herpes Simplex + logseq.order-list-type:: number + - Fungal logseq.order-list-type:: number + - [[Otomycosis]] + logseq.order-list-type:: number - Reactive Group logseq.order-list-type:: number - - [[Otomycosis]] + - [[Eczematous Otitis Externa]] logseq.order-list-type:: number - - [[Herpes Zoster Oticus]] + - [[Seborrhic Otitis Externa]] logseq.order-list-type:: number - - [[Otitis Externa Haemorrhagica]] - logseq.order-list-type:: number -- Others - - \ No newline at end of file + - [[Keratitis Obturans]] + logseq.order-list-type:: number \ No newline at end of file diff --git a/pages/Otitis Media with Effusion.md b/pages/Otitis Media with Effusion.md index c84a385..154bd29 100644 --- a/pages/Otitis Media with Effusion.md +++ b/pages/Otitis Media with Effusion.md @@ -1,71 +1,84 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease +alias:: OME, Glue Ear +ICD-11_Code:: +tags:: #Disease + +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ff02-d29d-46fa-a9c6-b8f1f6544728 - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents #ent-prof-written #unanswered #card + deck:: #ENT + id:: cf712701-e431-456e-b423-a4a876655d95 + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease #ent-prof-card #unanswered #card - deck:: #ENT - id:: e5e8984f-91b9-4523-b5d1-00400bfb2a81 - - ### Affected Systems/Organs -- ## Clinical Features + - ### Mechanism of Disease #ent-prof-card #unanswered #card + deck:: #ENT + id:: e5e8984f-91b9-4523-b5d1-00400bfb2a81 + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + id:: 01f76540-cb7c-4ef8-a154-d49c03cf558b + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + id:: 721febf5-0538-48d5-ab55-5a624f78a3b9 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ff5f-3b11-438c-a3eb-314789142181 \ No newline at end of file diff --git a/pages/Otitis Media.md b/pages/Otitis Media.md new file mode 100644 index 0000000..5dbfce4 --- /dev/null +++ b/pages/Otitis Media.md @@ -0,0 +1,74 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fa25-24af-43c9-8ce7-c49306615a0c +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: d1209344-b8fc-499e-a376-447fb4a003a2 + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue \ No newline at end of file diff --git a/pages/Otomycosis.md b/pages/Otomycosis.md index 6c89306..82ded31 100644 --- a/pages/Otomycosis.md +++ b/pages/Otomycosis.md @@ -1,9 +1,13 @@ -- #definition It is a fungal infection of external auditory canal +- #definition It is a fungal infection of external auditory canal #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6733ccee-4455-4ccc-aecc-9123043c28a7 - alias:: AA03 ICD-11_Code:: [[AA03]] tags:: #Disease -- ## Etiology +- ## Etiology #ent-prof-written #unanswered #card background-color:: blue + deck:: #ENT + id:: 6733ccee-75c3-49a6-8adf-01d9db0dbc53 - ### Causative Agents - _[[Aspergillus niger]]_ (black fungal ball) - _[[Aspergillus fumigatus]]_ (green) @@ -23,10 +27,10 @@ background-color:: blue - ### Mechanism of Disease - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 6733ccee-2abe-4542-a82e-a7e5755b34d6 + deck:: #ENT - ### Signs and Symptoms - #### Symptoms - Intense Itching @@ -36,9 +40,6 @@ - Watery Discharge with a musty odour - Ear blockage - fungal mass may appear white, brown or black and has been likened to a wet piece of filter paper - - On auriscopic findings - - Fungal ball or otomycotic plug - wet filter paper/ newspaper color of the ball - - Mucous membrane **swollen**, **reddish**, **congested** - ### Stages or Classification - ### Diagnostic Criteria - ## Diagnosis @@ -46,20 +47,21 @@ - ### Clinical Diagnosis : S/S - ### Investigations - Otoscope Findings - - A. niger appears black headed filamentous growth - - A. fumigatus as pale blue or green - - Candida as white or creamy deposit - - Meatal skin appear, *sodden, red * and *oedematous* + - Fungal ball or otomycotic plug - wet filter paper/ newspaper + - A. niger appears black headed filamentous growth + - A. fumigatus as pale blue or green + - Candida as white or creamy deposit + - Meatal skin appear, *sodden, red* and *oedematous* - Wet film preparation - Hyphae are found in aspergillus - Small ovoid budding is found in candida - Aural swab for C/S - ### Imaging Studies - ### Differential Diagnosis -- ## Management and Treatment #ent-prof-card #card #[[External Ear]] +- ## Management and Treatment #ent-prof-card #ent-prof-written #card #[[External Ear]] background-color:: blue - deck:: #ENT id:: 6733ccee-2f53-4849-b192-14e354d05c13 + deck:: #ENT - ### Surgical Options - For blockage: id:: 6733ccee-7980-4895-ad56-952edb6147b4 @@ -106,4 +108,7 @@ - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue \ No newline at end of file + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f8d6-dc67-41ec-b250-9de12becf15c \ No newline at end of file diff --git a/pages/Pain and Tenderness in Ear.md b/pages/Pain and Tenderness in Ear.md new file mode 100644 index 0000000..ae897da --- /dev/null +++ b/pages/Pain and Tenderness in Ear.md @@ -0,0 +1,3 @@ +# Management #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6757f824-50a9-422e-be86-286e8b7fce88 \ No newline at end of file diff --git a/pages/Parotid Gland Enlargement.md b/pages/Parotid Gland Enlargement.md new file mode 100644 index 0000000..9041045 --- /dev/null +++ b/pages/Parotid Gland Enlargement.md @@ -0,0 +1,3 @@ +# Causes #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6758109d-3c3d-4799-ae0a-966fca0752ed \ No newline at end of file diff --git a/pages/Plummer Vinson Syndrome.md b/pages/Plummer Vinson Syndrome.md new file mode 100644 index 0000000..10ac01e --- /dev/null +++ b/pages/Plummer Vinson Syndrome.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581274-8b47-479f-93b0-5edf85d77c61 \ No newline at end of file diff --git a/pages/Pre-auricular Sinus.md b/pages/Pre-auricular Sinus.md new file mode 100644 index 0000000..a0d5809 --- /dev/null +++ b/pages/Pre-auricular Sinus.md @@ -0,0 +1,72 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580553-dc10-46d6-b1f3-37887c42e645 \ No newline at end of file diff --git a/pages/Pure Tone Audiometry.md b/pages/Pure Tone Audiometry.md new file mode 100644 index 0000000..5b650c2 --- /dev/null +++ b/pages/Pure Tone Audiometry.md @@ -0,0 +1,5 @@ +alias:: PTA + +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580298-d5e4-4c7a-b8cf-ecce2a3bf3cc \ No newline at end of file diff --git a/pages/Ranula.md b/pages/Ranula.md new file mode 100644 index 0000000..1ad2f3f --- /dev/null +++ b/pages/Ranula.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816e2-5b7d-481f-83a9-8e20a55a39b3 \ No newline at end of file diff --git a/pages/Recurrent Miscarriage.md b/pages/Recurrent Miscarriage.md index a9a7ba6..edddd9c 100644 --- a/pages/Recurrent Miscarriage.md +++ b/pages/Recurrent Miscarriage.md @@ -1,4 +1,5 @@ alias:: Habitual Abortion -- #definition Recurrent Miscarriage is defined as a sequence of three or more consecutive spontaneous abortion before 20 weeks. #gyn-prof-card +- #definition {{c1 Recurrent Miscarriage is defined as a sequence of three or more consecutive spontaneous abortion before 20 weeks.}} #gyn-prof-card #card + deck:: #Gynecology - \ No newline at end of file diff --git a/pages/Reddish Mass of Nose.md b/pages/Reddish Mass of Nose.md new file mode 100644 index 0000000..89e0c46 --- /dev/null +++ b/pages/Reddish Mass of Nose.md @@ -0,0 +1,3 @@ +# Differential Diagnosis #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67580bfc-4f89-4b84-be34-80163f5350ca \ No newline at end of file diff --git a/pages/Referred Otalgia.md b/pages/Referred Otalgia.md index bc882f2..049b733 100644 --- a/pages/Referred Otalgia.md +++ b/pages/Referred Otalgia.md @@ -1,6 +1,9 @@ -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cdfe-6998-4b9b-b70f-d6fc70262a07 + deck:: #ENT - # Causes #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf34-9c7c-44ec-99e7-9e06e1a0eb22 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675804e8-a0f0-4856-b49a-972069eed24c \ No newline at end of file diff --git a/pages/Retropharyngeal abscess.md b/pages/Retropharyngeal abscess.md index 8969c43..fb49f83 100644 --- a/pages/Retropharyngeal abscess.md +++ b/pages/Retropharyngeal abscess.md @@ -1,71 +1,79 @@ - alias:: ICD-11_Code:: tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675810b0-fc80-45f7-806c-f4764d7c82be - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - [[Acute Retropharyngeal Abscess]] - - [[Chronic Retropharyngeal Abscess]] - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7f32f9e9-ccda-4242-aad5-0eedb0b3cb43 + - [[Acute Retropharyngeal Abscess]] + - [[Chronic Retropharyngeal Abscess]] + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581171-79d1-475c-a2f2-827bd0568291 \ No newline at end of file diff --git a/pages/Rhinnes Test.md b/pages/Rhinnes Test.md new file mode 100644 index 0000000..7b6aafe --- /dev/null +++ b/pages/Rhinnes Test.md @@ -0,0 +1,6 @@ +# Procedure #ent-prof-written #unanswered #card +deck:: #ENT +id:: 675801c6-ff43-416c-9c5d-5797946a05e7 +- # Interpretation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675801ca-09a5-4035-b98d-6e0cec84719f \ No newline at end of file diff --git a/pages/Rhinoplasty.md b/pages/Rhinoplasty.md new file mode 100644 index 0000000..16847b3 --- /dev/null +++ b/pages/Rhinoplasty.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d39-411f-4213-b2c9-25d117ce3e16 \ No newline at end of file diff --git a/pages/Rhinosporidiosis.md b/pages/Rhinosporidiosis.md index 90d3047..0feec16 100644 --- a/pages/Rhinosporidiosis.md +++ b/pages/Rhinosporidiosis.md @@ -1,75 +1,81 @@ - alias:: ICD-11_Code:: tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c17-1935-4c28-9aa1-56dad69bc9d2 - ## Etiology #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 120242e6-8089-4346-a09b-24c41a65d894 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #unanswered #card + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: d15cc573-58c4-4954-9664-4ee4841c91f8 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 95047ab4-df72-4522-9526-e1fe19c4e9b6 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c43-adc9-4abd-985f-da2724930a4d \ No newline at end of file diff --git a/pages/Rinne's Test.md b/pages/Rinne's Test.md new file mode 100644 index 0000000..9b47dc9 --- /dev/null +++ b/pages/Rinne's Test.md @@ -0,0 +1,9 @@ +# Procedure #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67580220-8cf9-417b-8718-a11493550724 +- # Interference #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580224-8c14-432f-8875-7683d9f1cefd +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758023b-32da-4a25-9014-9ddc0f1f112c \ No newline at end of file diff --git a/pages/Rough Query.md b/pages/Rough Query.md new file mode 100644 index 0000000..286371b --- /dev/null +++ b/pages/Rough Query.md @@ -0,0 +1,3 @@ +- {{query (and [[ent-prof-card]] [[ent-prof-written]])}} + query-properties:: [:block :page :deck] + query-table:: false \ No newline at end of file diff --git a/pages/Sensorineural Deafness.md b/pages/Sensorineural Deafness.md index 8799d38..14ad2b7 100644 --- a/pages/Sensorineural Deafness.md +++ b/pages/Sensorineural Deafness.md @@ -1,71 +1,5 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease -- ## Etiology - background-color:: blue - - ### Causative Agents #ent-prof-card #unanswered #card - deck:: #ENT - id:: dfded0b2-61c3-405f-b82f-52ebcc9b7283 - - ### Risk Factors -- ## Epidemiology - background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution -- ## Pathophysiology - background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs -- ## Clinical Features - background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria -- ## Diagnosis - background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment - background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up -- ## Prognosis - background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations -- ## Prevention - background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications -- ## Patient Education and Support - background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options -- ## Recent Research and Developments - background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances -- ## Key Literature - background-color:: blue -- ## Guidelines and Protocols - background-color:: blue +tags:: #Signs + +- # Causes #ent-prof-card #ent-prof-written #unanswered #card + id:: dfded0b2-61c3-405f-b82f-52ebcc9b7283 + deck:: #ENT \ No newline at end of file diff --git a/pages/Septal Abscess.md b/pages/Septal Abscess.md index 88ef737..71183e6 100644 --- a/pages/Septal Abscess.md +++ b/pages/Septal Abscess.md @@ -1,78 +1,83 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756c537-1205-46d8-91a0-cc1915f6ae4e + deck:: #ENT - ## Etiology #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 6756cf32-bc6a-478e-b20d-f7f4b03ce19c - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 9cf87f7c-b5ea-4dd9-a176-292616919594 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: da63716d-c270-4810-9403-4f1b6f1c1073 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 35f613dd-1108-499c-af39-932f6168400f + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580834-84ac-437b-9a11-14d51d49267e \ No newline at end of file diff --git a/pages/Septal Hematoma.md b/pages/Septal Hematoma.md index 585f912..e804713 100644 --- a/pages/Septal Hematoma.md +++ b/pages/Septal Hematoma.md @@ -4,73 +4,76 @@ - #definition - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-card #unanswered #card - deck:: #ENT - id:: 64266b0a-1aaa-42f1-8753-bdefd8d0e31a - - ### Risk Factors + - ### Causative Agents #ent-prof-card #unanswered #card + deck:: #ENT + id:: 64266b0a-1aaa-42f1-8753-bdefd8d0e31a + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 932292be-6531-4121-a91b-8f88bd317a67 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: a9a2e6bf-5e0f-4758-9453-efb3537e2918 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758093e-1bc3-48e4-9ca4-62f6d2ae503e \ No newline at end of file diff --git a/pages/Septoplasty.md b/pages/Septoplasty.md index 3cf20d5..09229e2 100644 --- a/pages/Septoplasty.md +++ b/pages/Septoplasty.md @@ -1 +1,18 @@ -- \ No newline at end of file +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756c4d5-1198-40ad-af3d-44cc31ef44e2 +- # Indication #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c95-feea-449d-add1-eb64e925ab6e +- # Advantages #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c9e-7fa0-4976-bfc3-1488c542ef85 +- # Disadvantages #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ca6-1545-42eb-a5a9-9e8840307b86 +- # Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c64-3671-45dc-921b-d12f0a939656 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d2a-5aa6-4808-950e-684bf8b0e35f \ No newline at end of file diff --git a/pages/Stridor.md b/pages/Stridor.md index d4b59eb..e3f72ce 100644 --- a/pages/Stridor.md +++ b/pages/Stridor.md @@ -1,9 +1,19 @@ tags:: #Signs -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756b3b2-dc1f-4fe6-8ec0-16f71c98fa2a -- # Causes #ent-prof-card #unanswered #card deck:: #ENT +- # Causes #ent-prof-card #ent-prof-written #unanswered #card id:: 6756b3bf-1f1a-4151-a1a2-dee3068c5861 -- + deck:: #ENT + - In Children +- # Investigation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758149f-ebc1-44f7-a02d-70f044729e25 +- # Management #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675814a7-b326-4e67-ac7d-be0491e1cb78 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756bba6-f30d-4b1a-9c28-e005696fde64 +- \ No newline at end of file diff --git a/pages/Submandibular Gland Surgery.md b/pages/Submandibular Gland Surgery.md new file mode 100644 index 0000000..1df7f4f --- /dev/null +++ b/pages/Submandibular Gland Surgery.md @@ -0,0 +1,6 @@ +# Complications #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67581059-1271-42b3-9c88-77ad1d7e679c +- # Which gland is commonly affected by sialothiasis? #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581076-54f8-436e-b3ef-3ee2041d5370 \ No newline at end of file diff --git a/pages/Submucosal Resection.md b/pages/Submucosal Resection.md index c3a4246..68b3c09 100644 --- a/pages/Submucosal Resection.md +++ b/pages/Submucosal Resection.md @@ -1 +1,5 @@ alias:: SMR + +- # Steps of SMR Operation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c86-6348-48f4-8cbb-2f83eefed3e6 \ No newline at end of file diff --git a/pages/Syringing the Ear.md b/pages/Syringing the Ear.md index cd276ef..2ea9da9 100644 --- a/pages/Syringing the Ear.md +++ b/pages/Syringing the Ear.md @@ -1 +1,6 @@ -# Procedure \ No newline at end of file +alias:: Aural Syringing +tags:: #[[Surgical Procedure]] + +- # Procedure #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675799a0-127b-434a-8fb6-1813e5800134 \ No newline at end of file diff --git a/pages/Tests of Ear.md b/pages/Tests of Ear.md new file mode 100644 index 0000000..a2c733d --- /dev/null +++ b/pages/Tests of Ear.md @@ -0,0 +1,9 @@ +# Names of the Tuning Fork Test #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6758012d-1afc-45b9-902f-6c706bbddfd3 + - [[Rhinnes Test]] + - [[Weber Test]] +- # Describe the Interpretation of Tuning Fork Test #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580166-a579-4844-8b86-293e806fcb4e +- \ No newline at end of file diff --git a/pages/Thryroglossal Duct.md b/pages/Thryroglossal Duct.md new file mode 100644 index 0000000..9a16dc4 --- /dev/null +++ b/pages/Thryroglossal Duct.md @@ -0,0 +1,72 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816dc-76d2-4cef-a2ca-1e3160849887 \ No newline at end of file diff --git a/pages/Thyroid Swelling.md b/pages/Thyroid Swelling.md new file mode 100644 index 0000000..e30bd51 --- /dev/null +++ b/pages/Thyroid Swelling.md @@ -0,0 +1,3 @@ +# Classification #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67581703-8f18-4c40-abbd-2174bf733403 \ No newline at end of file diff --git a/pages/Tongue Ulcer.md b/pages/Tongue Ulcer.md new file mode 100644 index 0000000..be754b4 --- /dev/null +++ b/pages/Tongue Ulcer.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581046-5be0-4710-b623-401ccef414af \ No newline at end of file diff --git a/pages/Tonsillectomy.md b/pages/Tonsillectomy.md index 5042eb9..a60b707 100644 --- a/pages/Tonsillectomy.md +++ b/pages/Tonsillectomy.md @@ -1,35 +1,50 @@ -# Indications #ent-prof-card #unanswered #card - -card-last-score:: 1 -card-repeats:: 1 -card-next-schedule:: 2024-12-07T18:00:00.000Z -card-last-interval:: -1 -id:: 6733ccee-2ae1-4595-b0f6-5f09375b1b25 -card-ease-factor:: 2.5 -card-last-reviewed:: 2024-12-07T09:10:10.080Z -deck:: #ENT - [[Recurrent Tonsillitis]] -logseq.order-list-type:: number - [[Quinsy]]: for the first time and also second time without tonsillitis -logseq.order-list-type:: number - Huge enlargement of the tonsil that causes obstructive symptoms like snoring, dyspnea, dysphagia etc -logseq.order-list-type:: number - Suspected malignancy (unilateral enlargement of tonsil, ulceration of tonsil) -logseq.order-list-type:: number - Other operative procedure like avulsion of styloid process, glossopharyngeal neurectomy -logseq.order-list-type:: number - +# Steps of Tonsillectomy Operation #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6758190d-d084-4b41-8fe8-53098f302a02 +- # Indications #ent-prof-card #ent-prof-written #unanswered #card + card-last-score:: 1 + card-repeats:: 1 + card-next-schedule:: 2024-12-07T18:00:00.000Z + card-last-interval:: -1 + id:: 6733ccee-2ae1-4595-b0f6-5f09375b1b25 + card-ease-factor:: 2.5 + card-last-reviewed:: 2024-12-07T09:10:10.080Z + deck:: #ENT - [[Recurrent Tonsillitis]] + - Huge enlargement of the tonsil that causes obstructive symptoms like snoring, dyspnea, dysphagia etc + logseq.order-list-type:: number + - Other operative procedure like avulsion of styloid process, glossopharyngeal neurectomy + logseq.order-list-type:: number - # Contraindication of tonsillectomy #ent-prof-card #unanswered #card deck:: #ENT id:: 6733ccee-0b37-4719-b633-2a9135cb80fd - - Acute upper respiratory infection because bleeding is more in the presence of acute infection (after resolution of infection, wait for 2 weeks) - - Bleeding disorder like hemophilia, aplastic anemia, ITP, leukemia - - Uncontrolled DM - - Uncontrolled hypertension - - Epidemic like disease - polio (it causes bulbar palsy) - - Overt or submucous -- # Complications #ent-prof-card #unanswered #card - deck:: #ENT + - Acute upper respiratory infection because bleeding is more in the presence of acute infection (after resolution of infection, wait for 2 weeks) + - Bleeding disorder like hemophilia, aplastic anemia, ITP, leukemia + - Uncontrolled DM + - Uncontrolled hypertension + - Epidemic like disease - polio (it causes bulbar palsy) + - Overt or submucous +- # Complications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756b151-9329-4f14-b5ad-804173e6d0dc - - [[Reactionary Hemorrhage]] -- # Management of Reactionary hemorrhage in Tonsillectomy #ent-prof-card #unanswered #card deck:: #ENT + - [[Reactionary Hemorrhage]] +- # Causes of Reactionary Hemorrhage in Post Tonsillectomy patient #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675819a0-0787-4039-bec0-b0d81237691f +- # Management of Reactionary hemorrhage in Tonsillectomy #ent-prof-card #unanswered #card id:: 6756b167-b5d3-45e4-a37e-8bda72a3ba58 + deck:: #ENT +- SN : Reactionary Hemorrhage after Tonsillectomy #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675819c8-91b5-4c11-ba12-252e413a579b +- # Causes of Secondary Hemorrhage #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675819e3-5452-469b-b3e9-7fb437863c2d - # Management of Secondary hemorrhage in Tonsillectomy #ent-prof-card #unanswered #card deck:: #ENT id:: 6756b183-ce0e-472b-9132-ca01bec19dae +- # Classify Hemorrhage in relation to tonsillectomy procedure #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758192d-2aad-4668-9b5d-95e48b941353 +- # Manage a case of Post Tonsillectomy Haemorrhage after 5 days of Tonsillectomy #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581a08-0ab5-415a-a6e2-79772cd055c0 \ No newline at end of file diff --git a/pages/Tracheostomy.md b/pages/Tracheostomy.md index 5b091be..cb06bd8 100644 --- a/pages/Tracheostomy.md +++ b/pages/Tracheostomy.md @@ -1,17 +1,28 @@ tags:: #[[Surgical Procedure]] -- # Indication #ent-prof-card #unanswered #card +- #definition {{c1 }} #ent-prof-written #unanswered #card deck:: #ENT + id:: 67581722-3531-4104-91ab-73d32249f47e +- # Aims/Objectives(How Does Tracheostomy Help a Patient) #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758172e-58d0-45bc-8d78-d13fcc61e306 +- # Indication #ent-prof-card #ent-prof-written #unanswered #card id:: 6756bb4f-9e5d-4db1-b83a-a512bcc575d2 + deck:: #ENT - # Steps of Tracheostomy #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf31-a107-4987-b45a-1438ce2609fa - # Types #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf31-bd80-4513-9079-4aa7d90d28c7 -- # Complications #ent-prof-card #unanswered #card - deck:: #ENT +- # Complications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf31-13c8-4242-aff7-89c661a83299 -- # Postoperative Care of a Tracheostomized Patient #ent-prof-card #unanswered #card deck:: #ENT + - peroperative + - Postoperative +- # Postoperative Care of a Tracheostomized Patient #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf31-300d-4849-9162-7cfa687f441a + deck:: #ENT +- SN: Emergency Tracheostomy/Tracheostomy #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581832-6df8-4455-9370-c9197f2c9a91 \ No newline at end of file diff --git a/pages/Tubotympanic Chronic Suppurative Otitis Media.md b/pages/Tubotympanic Chronic Suppurative Otitis Media.md index c3fca41..015befa 100644 --- a/pages/Tubotympanic Chronic Suppurative Otitis Media.md +++ b/pages/Tubotympanic Chronic Suppurative Otitis Media.md @@ -4,67 +4,71 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Anticoantral variety CSOM]] + - Differences #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fc97-f174-4d36-b902-2046198d31de + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Tympanic Membrane.md b/pages/Tympanic Membrane.md index 298ff83..868ab84 100644 --- a/pages/Tympanic Membrane.md +++ b/pages/Tympanic Membrane.md @@ -1,5 +1,17 @@ -# Parts #ent-prof-card #unanswered #card +alias:: Ear Drum -id:: 6756ce4d-a0eb-49b6-8900-ca2958757ab5 - -- ## deck:: #ENT +- # Parts #ent-prof-card #unanswered #card + id:: 6756ce4d-a0eb-49b6-8900-ca2958757ab5 + deck:: #ENT +- # Drawing and Labelling #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f920-b409-4035-ac18-08fa605588ba +- # Drawing and Labelling Tympanic Membrane showing **Central Perforation** #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f968-6d4f-4dee-9395-19ab2dc66e85 +- #Drawing and Labelling Tympanic Membrane showing Marginal Perforation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f984-43fa-49e8-b8ef-42052d8276cf +- # 5 causes of traumatic Injury to the Tympanic Memrbane #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f9c7-f5b3-46d3-af0b-ee3f47381dda \ No newline at end of file diff --git a/pages/Tympanoplasty.md b/pages/Tympanoplasty.md new file mode 100644 index 0000000..d25893e --- /dev/null +++ b/pages/Tympanoplasty.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580594-4015-4ff4-a19b-d09f07eec7b6 \ No newline at end of file diff --git a/pages/Vertigo.md b/pages/Vertigo.md index 2530e7a..07fe4d1 100644 --- a/pages/Vertigo.md +++ b/pages/Vertigo.md @@ -1,74 +1,74 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition {{c1 }} #ent-prof-card #unanswered #card - deck:: #ENT +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card id:: 6756c26e-8c76-4f88-9f40-061bbefc10dd + deck:: #ENT - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-card #unanswered #card - deck:: #ENT - id:: e11cf2f0-ae51-4057-a4e7-d30365595c1a - - ### Risk Factors + - ### Causative Agents #ent-prof-card #ent-prof-written #unanswered #card + id:: e11cf2f0-ae51-4057-a4e7-d30365595c1a + deck:: #ENT + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Waldeyer's Ring.md b/pages/Waldeyer's Ring.md index 45c7197..7b2b6b7 100644 --- a/pages/Waldeyer's Ring.md +++ b/pages/Waldeyer's Ring.md @@ -1,11 +1,15 @@ -# Constituents #ent-prof-card #unanswered #card - -deck:: #ENT -id:: 6756ad91-2397-4f01-93af-db93973ee577 - -deck:: #ENT -id:: 6756ad91-2397-4f01-93af-db93973ee577 - +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d87-ed89-4539-82ed-0b47c85244d5 +- # Drawing and Labelling Waldeyer's Ring #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d9f-480e-4481-acdc-2ed55842109c +- # Constituents #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756ad91-2397-4f01-93af-db93973ee577 - # Clinical Importance #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf30-0c4d-4a7d-b90c-8ed2e058783f +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580db4-8ec4-4061-a7fc-d56c2d831c7a \ No newline at end of file diff --git a/pages/Wax.md b/pages/Wax.md index 29b0f6c..3f96288 100644 --- a/pages/Wax.md +++ b/pages/Wax.md @@ -1,7 +1,10 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease -- #definition It is composed of desquamated epithelium, dirt, secretions of sebaceous (watery secretion) and seruminous gland (fatty secretion) +alias:: Ear Wax +ICD-11_Code:: +tags:: #Disease + +- #definition It is composed of desquamated epithelium, dirt, secretions of sebaceous (watery secretion) and seruminous gland (fatty secretion) #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6733ccef-a283-49df-8f0c-778297b4d0d1 - ## Composition - Desquamated Epithelium logseq.order-list-type:: number @@ -30,10 +33,10 @@ logseq.order-list-type:: number - Protection of ear from insect (foreign material) & dust logseq.order-list-type:: number -- ## Etiology #ent-prof-card #unanswered #card +- ## Etiology #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 6733ccef-7988-48c3-99dc-0de47e748645 + deck:: #ENT - ### Causative Agents - Long standing impacted wax may ulcerate the meatal skin & result in granuloma formation (_wax granuloma_) logseq.order-list-type:: number @@ -58,10 +61,10 @@ - ### Affected Systems/Organs - ((675798b9-1c47-4d4e-bf3f-f0e918a2c78c)) - ((67579897-adbd-4590-b33f-139f936b8701)) -- ## Clinical Features #ent-prof-card #card #[[External Ear]] +- ## Clinical Features #ent-prof-card #ent-prof-written #card #[[External Ear]] background-color:: blue - deck:: #ENT id:: 6733ccef-f88b-470f-b61d-dee5132df0ff + deck:: #ENT - ### Signs and Symptoms - #### Symptoms - Impariment of Hearing or Sense of Blocked ear @@ -87,7 +90,7 @@ - ### Laboratory Tests - ### Imaging Studies - ### Differential Diagnosis -- ## Management and Treatment #ent-prof-card #card #[[External Ear]] +- ## Management and Treatment #ent-prof-card #ent-prof-written #card #[[External Ear]] background-color:: blue id:: 6733ccef-220c-4ac9-8b57-a1bd92422057 deck:: #ENT diff --git a/pages/Weber Test.md b/pages/Weber Test.md new file mode 100644 index 0000000..7c86380 --- /dev/null +++ b/pages/Weber Test.md @@ -0,0 +1,6 @@ +# Procedure #ent-prof-written #unanswered #card +deck:: #ENT +id:: 675801fa-9fe5-44a7-aebe-e73992363a01 +- # Interference #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580202-90d4-487c-bd2e-9555e96b98a6 \ No newline at end of file diff --git a/pages/White Patches on the tonsil.md b/pages/White Patches on the tonsil.md index f628111..de39cc3 100644 --- a/pages/White Patches on the tonsil.md +++ b/pages/White Patches on the tonsil.md @@ -3,3 +3,6 @@ tags:: #Signs - # Differential Diagnosis #ent-prof-card #unanswered #ent-prof-written #card deck:: #ENT id:: 6756b1ae-51e0-4ba9-9220-dc162ef3b54e +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580f8a-746d-4c4f-9cfb-9db49c65b8a1 \ No newline at end of file diff --git a/pages/contents.md b/pages/contents.md index 049d959..4a1780b 100644 --- a/pages/contents.md +++ b/pages/contents.md @@ -1,2 +1,4 @@ - -- {{renderer :tocgen2, [[library]], calc(100vh - 135px)}} \ No newline at end of file +- {{renderer :tocgen2, [[library]], calc(100vh - 135px)}} +- {{renderer :tocgen2, [[rough query]], calc(100vh - 135px)}} +- {{renderer :tocgen2, [[rough query]], calc(100vh - 135px)}} \ No newline at end of file diff --git a/pages/ent-prof-written.md b/pages/ent-prof-written.md new file mode 100644 index 0000000..bb30740 --- /dev/null +++ b/pages/ent-prof-written.md @@ -0,0 +1 @@ +- c \ No newline at end of file diff --git a/pages/juvenile nasopharyngeal angiofibroma.md b/pages/juvenile nasopharyngeal angiofibroma.md index 1c9ab4f..2c9febc 100644 --- a/pages/juvenile nasopharyngeal angiofibroma.md +++ b/pages/juvenile nasopharyngeal angiofibroma.md @@ -2,4 +2,7 @@ - the tumor (oma) consists of blood vessels and fibrous tissue - male adolescent - profuse nose bleed(epitaxis) -- bipsy may be contraindicated \ No newline at end of file +- bipsy may be contraindicated +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580efb-a12a-4496-907a-890dbbe8effa \ No newline at end of file diff --git a/pages/larynx.md b/pages/larynx.md new file mode 100644 index 0000000..9c88bce --- /dev/null +++ b/pages/larynx.md @@ -0,0 +1,9 @@ +- Names of Cartilages of Larynx #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581402-788d-42f3-be49-e1d04717b078 +- # Functions #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758140d-72c2-41cf-a0f8-c6590beb7815 +- # Drawing and Labelling indirect view of Larynx #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581413-cd2a-4aea-a007-3042c6a4c00e \ No newline at end of file